RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: asthma
Accession: DOID:2841
browse the term
Definition: A bronchial disease that is characterized by chronic inflammation and narrowing of the airways, which is caused by a combination of environmental and genetic factors. The disease has_symptom recurring periods of wheezing (a whistling sound while breathing), has_symptom chest tightness, has_symptom shortness of breath, has_symptom mucus production and has_symptom coughing. (DO)
Synonyms: exact_synonym: AS1; asthmas; bronchial asthma
narrow_synonym: ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN; adult onset asthma; airway hyperresponsiveness
related_synonym: ASRT1; ASRT2; ASRT3; ASRT4; ASRT5; ASRT6; ASRT7; ASRT8; Asthma-Related Traits, Susceptibility To, 1; Asthma-Related Traits, Susceptibility To, 2; Asthma-Related Traits, Susceptibility To, 3; Asthma-Related Traits, Susceptibility To, 4; Asthma-Related Traits, Susceptibility To, 5; Asthma-Related Traits, Susceptibility To, 6; Asthma-Related Traits, Susceptibility To, 7; Asthma-Related Traits, Susceptibility To, 8; allergic airway inflammation; asthma and allergic rhinitis, susceptibility to; asthma and atopy, susceptibility to; asthma, protection against; asthma, susceptibility to; asthma-traits, susceptibility to asthma, protection against; beta-2-adrenoreceptor agonist, reduced response to; childhood athma, susceptibility to; rhinoconjunctivitis, susceptibility to
primary_id: MESH:D001249
alt_id: MIM:600807 ; MIM:601690 ; MIM:607277 ; MIM:608584 ; MIM:609958 ; MIM:610906 ; MIM:611064 ; MIM:611403 ; MIM:611960 ; MIM:613207
xref: EFO:0000270 ; EFO:0005414 ; EFO:1002011 ; GARD:10246 ; ICD10CM:J45 ; ICD9CM:493 ; MONDO:0004979 ; NCI:C28397
For additional species annotation, visit the
Alliance of Genome Resources .
G
ABCB1
ATP binding cassette subfamily B member 1
IEP
protein:increased expression:blood, lymphocyte
RGD
PMID:19484671
RGD:4890020
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
G
ABCC1
ATP binding cassette subfamily C member 1 (ABCC1 blood group)
ISO
RGD
PMID:18931056
RGD:5128825
NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
G
ABO
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
no_association
IAGP
RGD
PMID:19771478 PMID:16008680
RGD:5128835 , RGD:5128831
NCBI chr 9:133,250,401...133,275,201
Ensembl chr 9:133,233,278...133,276,024
G
ACE
angiotensin I converting enzyme
susceptibility
IAGP
DNA:polymorphism (human)
RGD
PMID:19484664 PMID:19383228
RGD:4140913 , RGD:4140919
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
G
ACSL3
acyl-CoA synthetase long chain family member 3
IDA
DNA:hypermethylation:promoter
RGD
PMID:19221603
RGD:13831295
NCBI chr 2:222,861,036...222,944,639
Ensembl chr 2:222,860,942...222,944,639
G
ADA
adenosine deaminase
susceptibility
IAGP
DNA:polymorphisms (human)
RGD
PMID:16754522
RGD:5128848
NCBI chr20:44,619,522...44,651,699
Ensembl chr20:44,584,896...44,652,252
G
ADAM33
ADAM metallopeptidase domain 33
no_association disease_progression susceptibility
ISO IAGP IEA IEP
mRNA:increased expression:lung DNA:SNPs:introns,exon:7575G>A, 11188A>T, 12433T>C (human) mRNA:increased expression:bronchus DNA:polymorphism: :p.M764T (human) DNA:SNPs: :multiple (human) DNA:SNPs (human)
RGD GAD
PMID:19635592 PMID:16893396 PMID:15118671 PMID:17339047 PMID:17961406 PMID:18778489 PMID:19940503 More...
RGD:4145360 , RGD:4145382 , RGD:1331525 , RGD:4145380 , RGD:4145379 , RGD:4145378 , RGD:4145359
NCBI chr20:3,667,975...3,682,010
Ensembl chr20:3,667,965...3,682,246
G
ADAM8
ADAM metallopeptidase domain 8
severity
ISO IEP
mRNA:increased expression:respiratory tract mRNA:increased expression:bronchus
RGD
PMID:19373511 PMID:17339047 PMID:20194813
RGD:5128878 , RGD:4145380 , RGD:5128872
NCBI chr10:133,262,423...133,276,868
Ensembl chr10:133,262,420...133,276,868
G
ADCY2
adenylate cyclase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21912604
NCBI chr 5:7,396,138...7,830,081
Ensembl chr 5:7,396,138...7,830,081
G
ADCYAP1R1
ADCYAP receptor type I
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21059121
NCBI chr 7:31,052,308...31,111,474
Ensembl chr 7:31,052,308...31,111,474
G
ADH5
alcohol dehydrogenase 5 (class III), chi polypeptide
susceptibility
ISO IAGP IEP
DNA:SNPs: :rs1154404, rs28730619 (human) protein:increased expression:respiratory system fluid/secretion
RGD
PMID:15919956 PMID:17543375 PMID:19395503 PMID:19514054
RGD:5128892 , RGD:5128882 , RGD:5128891 , RGD:5128890
NCBI chr 4:99,070,978...99,088,788
Ensembl chr 4:99,070,978...99,088,801
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
ISO
RGD
PMID:19168697
RGD:5686821
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
G
ADORA1
adenosine A1 receptor
IAGP ISO IEP
DNA:SNPs: :1405C>T (human) protein:increased expression:bronchus
RGD
PMID:19019667 PMID:20400685 PMID:17959644
RGD:4890386 , RGD:4145444 , RGD:5129097
NCBI chr 1:203,127,726...203,167,405
Ensembl chr 1:203,090,654...203,167,405
G
ADORA2A
adenosine A2a receptor
ISO IAGP
mRNA:decreased expression:aorta DNA:SNP (human)
RGD
PMID:17293374 PMID:18310516 PMID:19019667 PMID:16339780
RGD:4890380 , RGD:4890366 , RGD:4890386 , RGD:4890385
NCBI chr22:24,423,597...24,442,357
Ensembl chr22:24,417,879...24,442,357
G
ADRB2
adrenoceptor beta 2
susceptibility
IAGP IDA ISO IEA
DNA:polymorphism: :p.R16G (human) ClinVar Annotator: match by term: Beta-2-adrenoreceptor agonist, reduced response to DNA:SNP: :p.Q27E (human) DNA:SNPs:promoter:multiple (human) DNA:SNPs: :p.R16G, p.Q27E (human) DNA:SNP: :-1023A>G (human)
ClinVar RGD
PMID:8383511 PMID:15284533 PMID:16596417 PMID:19800676 PMID:1655856 PMID:18569231 PMID:20004781 PMID:20443840 PMID:19423772 PMID:18785519 PMID:19638684 PMID:15118671 PMID:19029431 More...
RGD:4145061 , RGD:5129113 , RGD:4145096 , RGD:4145105 , RGD:4145108 , RGD:4145107 , RGD:4145094 , RGD:4145081 , RGD:1331525 , RGD:4145092
NCBI chr 5:148,826,611...148,828,623
Ensembl chr 5:148,826,611...148,828,623
G
AGER
advanced glycosylation end-product specific receptor
treatment onset
IEP EXP ISO
CTD Direct Evidence: marker/mechanism protein:decreased expression:lung (rat)
CTD RGD
PMID:23304218 PMID:33075463 PMID:21920897 PMID:23304218
RGD:7244279 , RGD:6767554 , RGD:7244279
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
G
AGTR1
angiotensin II receptor type 1
ISO
RGD
PMID:17877756 PMID:19080339
RGD:5147452 , RGD:5147457
NCBI chr 3:148,697,903...148,743,003
Ensembl chr 3:148,697,784...148,743,008
G
AGTR2
angiotensin II receptor type 2
ISO
mRNA, protein:increased expression:lung
RGD
PMID:19080339
RGD:5147457
NCBI chr X:116,170,744...116,174,974
Ensembl chr X:116,170,744...116,174,974
G
ALDH2
aldehyde dehydrogenase 2 family member
IEA EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:9600491 PMID:11506308 PMID:15118671
RGD:1331525
NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
G
ALOX15
arachidonate 15-lipoxygenase
ISO
protein:increased expression:lung
RGD
PMID:19628725 PMID:18692885
RGD:5509605 , RGD:5509784
NCBI chr17:4,630,919...4,641,678
Ensembl chr17:4,630,919...4,642,294
G
ALOX5
arachidonate 5-lipoxygenase
no_association treatment severity
IAGP EXP IEP ISO IMP
DNA:polymorphism:promoter (human) CTD Direct Evidence: marker/mechanism mRNA:increased expression:blood, leukocyte protein:increased expression:lung DNA:repeat:promoter (human) DNA:polymorphism:cds:p.E254K (human)
OMIM CTD RGD
PMID:20128419 PMID:9642160 PMID:12911785 PMID:8879219 PMID:19033731 PMID:11035107 PMID:10369259 PMID:17394438 PMID:16364163 PMID:18204779 More...
RGD:4890407 , RGD:5147467 , RGD:5147465 , RGD:5147462 , RGD:4890408 , RGD:4890422 , RGD:734557 , RGD:4890413 , RGD:4890415 , RGD:4890410
NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119
G
ALOX5AP
arachidonate 5-lipoxygenase activating protein
no_association susceptibility
IAGP IEP ISO
DNA:polymorphism:promoter (human) mRNA:increased expression:blood, leukocyte DNA:repeat:promoter:-169(A)21 (human) DNA:substitution, repeat:promoter:-336G>A, -169(A)19-23 (human) DNA:polymorphisms:intron:IVS2+12C>A, IVS2+105T>C (human) protein:increased expression:lung DNA:SNPs (human) DNA:SNP: :rs10507391 (human)
RGD
PMID:20128419 PMID:9642160 PMID:10527888 PMID:12911785 PMID:15784112 PMID:8879219 PMID:11035107 PMID:18547289 PMID:20067482 More...
RGD:4890407 , RGD:5147467 , RGD:5147466 , RGD:5147465 , RGD:5147464 , RGD:5147462 , RGD:4890422 , RGD:4890409 , RGD:4890405
NCBI chr13:30,713,485...30,764,426
Ensembl chr13:30,713,478...30,764,426
G
AMBP
alpha-1-microglobulin/bikunin precursor
IEP
protein:increased expression:serum
RGD
PMID:14621078
RGD:6904149
NCBI chr 9:114,060,127...114,078,300
Ensembl chr 9:114,060,127...114,078,328
G
ANG
angiogenin
severity
IEP
protein:increased expression:sputum
RGD
PMID:16478840
RGD:6892719
NCBI chr14:20,684,177...20,694,186
Ensembl chr14:20,684,177...20,698,971
G
ANXA1
annexin A1
ISO
RGD
PMID:22092555
RGD:7421657
NCBI chr 9:73,151,865...73,170,393
Ensembl chr 9:73,151,865...73,170,629
G
AREG
amphiregulin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15696081
NCBI chr 4:74,445,136...74,455,005
Ensembl chr 4:74,445,136...74,455,005
G
ARG1
arginase 1
IAGP EXP ISO IEP
DNA:SNP: :rs2781667 (human) CTD Direct Evidence: marker/mechanism mRNA:increased expression:lung (mouse) mRNA, protein:increased expression:lung, mononuclear cell (human)
CTD RGD
PMID:19281908 PMID:19800904 PMID:20124949 PMID:12813022 PMID:12813022
RGD:5129205 , RGD:4143187 , RGD:4143187
NCBI chr 6:131,573,226...131,584,329
Ensembl chr 6:131,470,832...131,584,332
G
ARG2
arginase 2
severity susceptibility
IAGP EXP ISO
DNA:SNP: :rs3742879, rs17249437 (human) CTD Direct Evidence: marker/mechanism mRNA:increased expression:lung (mouse) DNA:SNPs (human)
CTD RGD
PMID:19281908 PMID:20124949 PMID:12813022 PMID:16387594
RGD:5129205 , RGD:4143187 , RGD:5129207
NCBI chr14:67,619,920...67,651,708
Ensembl chr14:67,619,920...67,651,708
G
BCL2
BCL2 apoptosis regulator
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18357729
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
BDKRB2
bradykinin receptor B2
onset
IAGP IEP IMP ISO
DNA:polymorphism:exon (human) protein:increased expression:blood, eosinophil
RGD
PMID:11517947 PMID:19038786 PMID:8856156 PMID:14727005
RGD:4890456 , RGD:4891028 , RGD:4891042 , RGD:4890454
NCBI chr14:96,204,839...96,244,164
Ensembl chr14:96,204,679...96,244,166
G
BDNF
brain derived neurotrophic factor
susceptibility severity
IDA IAGP IEP
DNA:SNP,haplotypes: :rs10767664,rs12273539,rs962369(human) DNA:polymorphisms: :p.V66M, -270C>T (human) DNA:polymorphisms: :p.V66M (rs6265) (human) protein:increased expression:plasma protein:decreased expression:blood, eosinophil
RGD
PMID:11737043 PMID:21723144 PMID:17584309 PMID:19895626 PMID:20874832 PMID:12752594 More...
RGD:4891123 , RGD:8655967 , RGD:4891067 , RGD:4891117 , RGD:4891063 , RGD:4891122
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
G
BGLAP
bone gamma-carboxyglutamate protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:8429434
NCBI chr 1:156,242,184...156,243,317
Ensembl chr 1:156,242,184...156,243,317
G
BMPR1B
bone morphogenetic protein receptor type 1B
IEP
protein:decreased expression:bronchus
RGD
PMID:18292470
RGD:5129470
NCBI chr 4:94,757,955...95,158,450
Ensembl chr 4:94,757,955...95,158,448
G
BMPR2
bone morphogenetic protein receptor type 2
IEP
protein:decreased expression:bronchus
RGD
PMID:18292470
RGD:5129470
NCBI chr 2:202,376,327...202,567,749
Ensembl chr 2:202,376,327...202,567,751
G
C3
complement C3
severity
ISO IEP IAGP
protein:increased expression:respiratory system fluid/secretion protein:increased expression:serum Interaction with IL4RA DNA:SNP:intron:rs11569562 (human) DNA:SNPs: :multiple (human) DNA:SNP: :4896C>T (human)
RGD
PMID:20802484 PMID:20589464 PMID:20402389 PMID:20395963 PMID:18566738 PMID:16355111 PMID:15278436 PMID:11591733 More...
RGD:5129681 , RGD:5129519 , RGD:5129537 , RGD:5129538 , RGD:5129501 , RGD:5129505 , RGD:5129512 , RGD:5129517
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
G
C3AR1
complement C3a receptor 1
severity
ISO IAGP IEP
mRNA:increased expression:lung protein:increased expression:lung, leukocyte
RGD
PMID:20045013 PMID:15278436 PMID:20802484 PMID:17544263 PMID:17544263 PMID:15940127 More...
RGD:5129686 , RGD:5129512 , RGD:5129681 , RGD:5129560 , RGD:5129560 , RGD:5129561
NCBI chr12:8,056,844...8,066,359
Ensembl chr12:8,056,844...8,066,359
G
C5
complement C5
severity
IAGP ISO IEP
mRNA:decreased expression:lung
RGD
PMID:15278436 PMID:20802484 PMID:20143644 PMID:11591795 PMID:10973279
RGD:5129512 , RGD:5129681 , RGD:5129706 , RGD:1600651 , RGD:5130158
NCBI chr 9:120,952,335...121,074,865
Ensembl chr 9:120,932,987...121,075,195
G
C5AR1
complement C5a receptor 1
severity
ISO IEP
protein:increased expression:respiratory tract protein:increased expression:lung, leukocyte
RGD
PMID:20802484 PMID:15940127 PMID:16511606 PMID:17544263
RGD:5129681 , RGD:5129561 , RGD:5130166 , RGD:5129560
NCBI chr19:47,307,477...47,322,066
Ensembl chr19:47,290,023...47,322,066
G
CARD11
caspase recruitment domain family member 11
susceptibility
ISO IAGP
ClinVar Annotator: match by term: Asthma
ClinVar RGD
PMID:18323416 PMID:23027925 PMID:23129749 PMID:25352053 PMID:25741868 PMID:26861442 PMID:28492532 PMID:28824638 PMID:29472930 PMID:16751370 More...
RGD:11100037
NCBI chr 7:2,906,142...3,043,867
Ensembl chr 7:2,906,142...3,044,228
G
CARD11-AS1
CARD11 antisense RNA 1
IAGP
ClinVar Annotator: match by term: Asthma
ClinVar
PMID:18323416 PMID:23027925 PMID:23129749 PMID:25352053 PMID:25741868 PMID:26861442 PMID:28492532 PMID:28824638 PMID:29472930 More...
NCBI chr 7:2,944,035...2,947,087
Ensembl chr 7:2,944,027...2,947,091
G
CARM1
coactivator associated arginine methyltransferase 1
ISO
mRNA:decreased expression:lung
RGD
PMID:20423833
RGD:9491823
NCBI chr19:10,871,553...10,923,075
Ensembl chr19:10,871,553...10,923,075
G
CASP1
caspase 1
IEP
protein:increased expression:serum
RGD
PMID:12396474
RGD:5130192
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
G
CAT
catalase
severity
IEP EXP IDA IAGP
protein:increased expression:erythrocyte CTD Direct Evidence: marker/mechanism protein:decreased activity:respiratory system fluid/secretion DNA:polymorphism:promoter:-262C>T (human) DNA:polymorphism:promoter:-21A>T (human)
CTD RGD
PMID:18048809 PMID:19475625 PMID:16622028 PMID:18048809 PMID:19373626
RGD:5130751 , RGD:5130867 , RGD:5130856 , RGD:5130753
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CCL1
C-C motif chemokine ligand 1
IEP
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:20455898
RGD:4891420
NCBI chr17:34,360,328...34,363,233
Ensembl chr17:34,360,328...34,363,233
G
CCL11
C-C motif chemokine ligand 11
treatment susceptibility severity
ISO IAGP EXP IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:plasma DNA:polymorphism: :p.A23T (human) mRNA:increased expression:lung
OMIM CTD RGD
PMID:17060636 PMID:22932891 PMID:16304252 PMID:17074272 PMID:9034156 PMID:17845580 PMID:18250471 PMID:20704746 More...
RGD:4891485 , RGD:7248416 , RGD:5130930 , RGD:4145461 , RGD:4145451 , RGD:4145457 , RGD:4145392 , RGD:4145387
NCBI chr17:34,285,742...34,288,334
Ensembl chr17:34,285,742...34,288,334
G
CCL17
C-C motif chemokine ligand 17
ISO IEP
mRNA:increased expression:lung protein:increased expression:respiratory system fluid/secretion
RGD
PMID:15993846 PMID:20074456 PMID:15947487 PMID:20237293 PMID:11160256
RGD:2306304 , RGD:4145487 , RGD:4145513 , RGD:4145486 , RGD:4145603
NCBI chr16:57,396,093...57,416,063
Ensembl chr16:57,404,767...57,416,063
G
CCL19
C-C motif chemokine ligand 19
IEP
protein:increased expression:bronchus submucosa, mast cell
RGD
PMID:16959919
RGD:5130911
NCBI chr 9:34,689,570...34,691,276
Ensembl chr 9:34,689,570...34,691,276
G
CCL2
C-C motif chemokine ligand 2
treatment severity
IEP EXP ISO IAGP
CTD Direct Evidence: marker/mechanism mRNA:increased expression:lung (mouse) DNA:haplotype::-2518A>G (human) protein:increased expression:lung protein:increased expression:serum
CTD RGD
PMID:19373627 PMID:20205697 PMID:12055264 PMID:25441643 PMID:23454776 PMID:17964702 PMID:19373627 More...
RGD:4145509 , RGD:11528570 , RGD:11528569 , RGD:8551842 , RGD:2307055 , RGD:4891466
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCL20
C-C motif chemokine ligand 20
IEP
protein:increased expression:respiratory system fluid/secretion associated with Allergic Rhinitis;protein:increased expression:serum
RGD
PMID:18422729 PMID:22469443
RGD:7483597 , RGD:7483618
NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564
G
CCL22
C-C motif chemokine ligand 22
ISO IEP
protein:increased expression:respiratory system fluid/secretion mRNA, protein:increased expression:respiratory system mucosa, respiratory system fluid/secretion mRNA:increased expression:lung
RGD
PMID:18316417 PMID:10384142 PMID:18684970 PMID:15993846
RGD:4891474 , RGD:4891475 , RGD:4145489 , RGD:2306304
NCBI chr16:57,357,909...57,366,189
Ensembl chr16:57,358,783...57,366,189
G
CCL24
C-C motif chemokine ligand 24
susceptibility
IAGP IEP ISO IMP
DNA:SNP: :1265A>G (human) protein:increased expression:plasma DNA:SNPs: :179T>C, 275C>T (human) DNA:SNPs: :304C>A, 1272A>G (human) protein:increased expression:respiratory system fluid/secretion
RGD
PMID:12761043 PMID:16304252 PMID:15207712 PMID:18712274 PMID:17060636 PMID:17548626 PMID:12952266 More...
RGD:5130932 , RGD:5130930 , RGD:4891495 , RGD:4891483 , RGD:4891485 , RGD:4891484 , RGD:4891496
NCBI chr 7:75,810,825...75,823,372
Ensembl chr 7:75,810,825...75,823,356
G
CCL26
C-C motif chemokine ligand 26
treatment
IAGP ISO IEP
DNA:SNPs: :77C>T, 716A>G, 1579G>A (human) protein:increased expression:plasma DNA:SNPs: :77C>T, 2497T>G (human)
RGD
PMID:18712274 PMID:25399816 PMID:25530546 PMID:16304252 PMID:15207712
RGD:4891483 , RGD:11087575 , RGD:11081163 , RGD:5130930 , RGD:4891495
NCBI chr 7:75,769,524...75,791,597
Ensembl chr 7:75,769,533...75,789,896
G
CCL27
C-C motif chemokine ligand 27
IEP
RGD
PMID:19541356
RGD:5130899
NCBI chr 9:34,661,890...34,662,657
Ensembl chr 9:34,661,880...34,664,048
G
CCL28
C-C motif chemokine ligand 28
ISO
mRNA:increased expression:lung (mouse)
RGD
PMID:16290206
RGD:4892195
NCBI chr 5:43,356,975...43,412,391
Ensembl chr 5:43,376,645...43,412,391
G
CCL4
C-C motif chemokine ligand 4
IEP
RGD
PMID:18774390
RGD:5130915
NCBI chr17:36,103,827...36,105,614
Ensembl chr17:36,103,827...36,105,621
G
CCL5
C-C motif chemokine ligand 5
susceptibility
ISO EXP IAGP
protein:increased expression:lung, secretion (mouse) CTD Direct Evidence: marker/mechanism protein:increased expression:smooth muscle cell DNA:transition:5' utr:-403G>A (human)
CTD RGD
PMID:8534483 PMID:20092989 PMID:18208670 PMID:20430255
RGD:4891430 , RGD:2307112 , RGD:4891381
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
CCL7
C-C motif chemokine ligand 7
ISO IEP
Promoter polymorphism
RGD
PMID:19965981 PMID:21388664
RGD:5130979 , RGD:5130983
NCBI chr17:34,270,221...34,272,242
Ensembl chr17:34,270,221...34,272,242
G
CCR1
C-C motif chemokine receptor 1
severity
ISO
mRNA:increased expression:lung associated with Respiratory Syncytial Virus Infections
RGD
PMID:15654816 PMID:15593301
RGD:5688158 , RGD:5688159
NCBI chr 3:46,201,711...46,208,313
Ensembl chr 3:46,201,711...46,208,313
G
CCR2
C-C motif chemokine receptor 2
susceptibility
IAGP ISO
DNA:SNP:cds:p.V64I (human) DNA:haplotype:cds:p.V64I(human) protein:increased expression:lung, dendritic cell (mouse)
RGD
PMID:17298432 PMID:23454776 PMID:19917684
RGD:4145110 , RGD:8551842 , RGD:8549811
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
G
CCR3
C-C motif chemokine receptor 3
ISO IEP IAGP
protein:increased expression:respiratory system fluid/secretion, neutrophil DNA:SNP:exon:51T>C (human)
RGD
PMID:16978084 PMID:19017998 PMID:20220260 PMID:19657453 PMID:20134116 PMID:18699933 PMID:17145927 More...
RGD:4145646 , RGD:4145632 , RGD:4145638 , RGD:4145623 , RGD:4145618 , RGD:4145633 , RGD:1601020
NCBI chr 3:46,210,696...46,266,706
Ensembl chr 3:46,130,890...46,266,706
G
CCR4
C-C motif chemokine receptor 4
ISO
mRNA:increased expression:lung
RGD
PMID:15993846
RGD:2306304
NCBI chr 3:32,951,644...32,956,349
Ensembl chr 3:32,951,644...32,957,120
G
CCR5
C-C motif chemokine receptor 5
no_association
IEP IAGP ISO
protein:decreased expression:blood, lymphocyte (human) DNA:polymorphism, frameshift mutation: :-59029G>A, p.S185_T195del (rs333) (human) DNA:frameshift mutation:cds:p.S185_T195del rs333 (human) mRNA:increased expression:lung (mouse)
RGD
PMID:15256090 PMID:23454776 PMID:16474097 PMID:20220260 PMID:18094012
RGD:4892108 , RGD:8551842 , RGD:4892093 , RGD:4145638 , RGD:4892088
NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206
G
CCR6
C-C motif chemokine receptor 6
ISO
protein:increased expression:lung, dendritic cell (mouse)
RGD
PMID:19917684
RGD:8549811
NCBI chr 6:167,111,795...167,139,141
Ensembl chr 6:167,111,807...167,139,141
G
CCR7
C-C motif chemokine receptor 7
ISO
protein:increased expression:lung, dendritic cell (mouse)
RGD
PMID:19917684
RGD:8549811
NCBI chr17:40,553,769...40,565,472
Ensembl chr17:40,551,081...40,565,472
G
CCR8
C-C motif chemokine receptor 8
ISO
mRNA:increased expression:lung
RGD
PMID:15993846
RGD:2306304
NCBI chr 3:39,329,709...39,333,680
Ensembl chr 3:39,329,709...39,333,680
G
CCR9
C-C motif chemokine receptor 9
IEP
mRNA, protein:increased expression:blood, mature NK T cell
RGD
PMID:16210593
RGD:5130925
NCBI chr 3:45,886,064...45,903,174
Ensembl chr 3:45,884,425...45,903,174
G
CD14
CD14 molecule
no_association severity susceptibility
IAGP EXP IEP
DNA:polymorphism:promoter:c. -159C>T (human) CTD Direct Evidence: marker/mechanism DNA:SNPs: : protein:increased expression:serum protein:increased expression:serum|DNA:polymorphism:promoter:c. -159C>T (human) DNA:polymorphism:promoter:c. -260C>T (human)
CTD RGD
PMID:17607003 PMID:15741437 PMID:19096003 PMID:16387800 PMID:16387800 PMID:18312481 PMID:15940135 More...
RGD:4144815 , RGD:4144228 , RGD:4144813 , RGD:4144813 , RGD:4144208 , RGD:4144814
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
G
CD1D
CD1d molecule
susceptibility
ISO
associated with fasciolopsiasis
RGD
PMID:20304473
RGD:4140417
NCBI chr 1:158,178,030...158,186,427
Ensembl chr 1:158,178,030...158,186,427
G
CD209
CD209 molecule
IEP
RGD
PMID:21471959
RGD:5131188
NCBI chr19:7,739,993...7,747,534
Ensembl chr19:7,739,993...7,747,564
G
CD274
CD274 molecule
treatment
ISO
associated with Chlamydia pneumonia
RGD
PMID:26378990
RGD:41412180
NCBI chr 9:5,450,542...5,470,554
Ensembl chr 9:5,450,503...5,470,566
G
CD28
CD28 molecule
IEP
RGD
PMID:21356099
RGD:5131612
NCBI chr 2:203,706,482...203,738,912
Ensembl chr 2:203,706,517...203,739,756
G
CD40
CD40 molecule
treatment
IEP ISO IAGP
RGD
PMID:19220210 PMID:20205594 PMID:20941750 PMID:19159017
RGD:5132272 , RGD:8547792 , RGD:4892277 , RGD:4144188
NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
G
CD40LG
CD40 ligand
severity
ISO
RGD
PMID:9502776
RGD:11352238
NCBI chr X:136,648,158...136,660,390
Ensembl chr X:136,648,158...136,660,390
G
CD80
CD80 molecule
ISO
RGD
PMID:21352203 PMID:21051864 PMID:21440530
RGD:5132620 , RGD:5132621 , RGD:5132619
NCBI chr 3:119,524,293...119,559,614
Ensembl chr 3:119,524,293...119,559,614
G
CD86
CD86 molecule
treatment
ISO IEP IAGP
protein:increased expression:lung, alveolar macrophage (mouse) protein:increased expression:blood, B cell (human) protein:increased expression:lung, dendritic cell (rat) DNA:snp:exon:p.I179V rs2681417 (human)
RGD
PMID:20941750 PMID:25344652 PMID:9449507 PMID:20668438 PMID:9551945 PMID:17513529 More...
RGD:4892277 , RGD:11354965 , RGD:4892555 , RGD:4892199 , RGD:4892202 , RGD:4892280
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
G
CDH1
cadherin 1
IAGP
RGD
PMID:21540309
RGD:5132878
NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
G
CDHR3
cadherin related family member 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24241537
NCBI chr 7:105,963,264...106,036,432
Ensembl chr 7:105,876,796...106,036,432
G
CFTR
CF transmembrane conductance regulator
susceptibility
IAGP
DNA:deletion: :p.F508del(human)
RGD
PMID:20298391
RGD:4140387
NCBI chr 7:117,480,025...117,668,665
Ensembl chr 7:117,287,120...117,715,971
G
CHAT
choline O-acetyltransferase
ISO
Protein:decreased expression:lung epithelium
RGD
PMID:17328924
RGD:5686690
NCBI chr10:49,609,095...49,667,942
Ensembl chr10:49,609,095...49,667,942
G
CHI3L1
chitinase 3 like 1
susceptibility
IMP IAGP IEP
human gene in mouse model ClinVar Annotator: match by term: Asthma-related traits, susceptibility to, 7 DNA:snp:5' utr:g.-131C>G rs4950928 (human) protein:increased secretion:serum (human)
OMIM ClinVar RGD
PMID:18403759 PMID:19414556 PMID:19568425 PMID:18003958
RGD:4892663 , RGD:4892630 , RGD:4892632
NCBI chr 1:203,178,931...203,186,704
Ensembl chr 1:203,178,931...203,186,704
G
CHIA
chitinase acidic
no_association
IAGP ISO IEP
DNA:snps:5' utr, cds:multiple (human) DNA:snps:multiple (human) mRNA:increased expression:lung, epithelial cell (human) mRNA:increased expression:lung (mouse)
RGD
PMID:16179638 PMID:20226308 PMID:19548841 PMID:15192232 PMID:14734765
RGD:4996473 , RGD:5024922 , RGD:5024921 , RGD:4985150 , RGD:4990463
NCBI chr 1:111,290,851...111,320,563
Ensembl chr 1:111,290,851...111,320,566
G
CHML
CHM like Rab escort protein
IAGP
RGD
PMID:18343558
RGD:5133238
NCBI chr 1:241,628,851...241,640,369
Ensembl chr 1:241,628,851...241,640,369
G
CHRM1
cholinergic receptor muscarinic 1
IAGP
RGD
PMID:16931638
RGD:5133416
NCBI chr11:62,908,679...62,921,878
Ensembl chr11:62,908,679...62,921,807
G
CHRM2
cholinergic receptor muscarinic 2
IAGP
DNA:SNP: :rs6962027 (human)
RGD
PMID:19308904
RGD:5509586
NCBI chr 7:136,868,652...137,020,213
Ensembl chr 7:136,868,652...137,020,255
G
CHRM3
cholinergic receptor muscarinic 3
severity
IEP ISO
RGD
PMID:20394512 PMID:18348887
RGD:5133437 , RGD:5133438
NCBI chr 1:239,386,568...239,915,450
Ensembl chr 1:239,386,565...239,915,452
G
CHUK
component of inhibitor of nuclear factor kappa B kinase complex
ISO
RGD
PMID:21496385
RGD:5133703
NCBI chr10:100,186,319...100,229,596
Ensembl chr10:100,188,300...100,229,596
G
CLCA1
chloride channel accessory 1
susceptibility
IDA ISO IAGP
DNA:SNPs (human)
RGD
PMID:17898169 PMID:11296262 PMID:15318163
RGD:4145653 , RGD:4145661 , RGD:4145656
NCBI chr 1:86,468,927...86,500,259
Ensembl chr 1:86,468,368...86,500,259
G
CLDN18
claudin 18
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:27215490
NCBI chr 3:137,998,816...138,033,649
Ensembl chr 3:137,998,735...138,033,655
G
CMA1
chymase 1
severity no_association susceptibility
IEP IAGP
protein:increased expression:lung epithelium, mast cell (human) DNA:polymorphism:5' utr:g.-1903G>A rs1800875 (human) DNA:duplications:3' utr:g.*254-?dupTG, dupGA (human)
RGD
PMID:20813890 PMID:15248847 PMID:15924217
RGD:5128804 , RGD:1625397 , RGD:1625396
NCBI chr14:24,505,353...24,508,265
Ensembl chr14:24,505,353...24,508,265
G
CRHR1
corticotropin releasing hormone receptor 1
IAGP
DNA:SNP: :RS242941 (human) DNA:SNPs: :rs1876828, rs242939, rs242941 (human)
RGD
PMID:19663668 PMID:16113459
RGD:5147485 , RGD:5147488
NCBI chr17:45,784,320...45,835,828
Ensembl chr17:45,784,277...45,835,828
G
CRHR2
corticotropin releasing hormone receptor 2
IAGP
DNA:SNPs: :multiple (human)
RGD
PMID:18408560
RGD:5130938
NCBI chr 7:30,651,942...30,700,103
Ensembl chr 7:30,651,942...30,700,129
G
CRP
C-reactive protein
IEP
protein:increased expression:serum
RGD
PMID:21140796
RGD:5131288
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
G
CSF2
colony stimulating factor 2
severity
ISO IEP
protein:increased expression:lung protein:increased expression:sputum
RGD
PMID:20405019 PMID:9717963 PMID:19213775
RGD:5131473 , RGD:10449521 , RGD:5131476
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
G
CSF2RB
colony stimulating factor 2 receptor subunit beta
ISO
RGD
PMID:17145927
RGD:1601020
NCBI chr22:36,913,628...36,940,439
Ensembl chr22:36,913,628...36,940,439
G
CSF3
colony stimulating factor 3
IDA ISO
protein:increased expression:lung
RGD
PMID:21396376 PMID:20405019
RGD:5133731 , RGD:5131473
NCBI chr17:40,015,440...40,017,813
Ensembl chr17:40,015,361...40,017,813
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
severity treatment no_association
IEP EXP ISO IDA IAGP
protein:increased expression:serum CTD Direct Evidence: marker/mechanism DNA:SNP: :rs3087243 (human) DNA:polymorphism:promoter:-318C>T (human) DNA:SNPs:promoter, exon:-1147C>T, -318C>T, 49A>G (human) DNA:SNPs: :multiple (human) DNA:polymorphisms:promoter, exon:-318C>T 49A>G (human)
CTD RGD
PMID:28807506 PMID:15871446 PMID:11726402 PMID:17237396 PMID:16677453 PMID:18699801 PMID:19895365 PMID:12114354 PMID:12956753 PMID:16926542 PMID:16708626 PMID:15316504 PMID:17469155 More...
RGD:4891529 , RGD:11344922 , RGD:4891514 , RGD:4891517 , RGD:4891510 , RGD:4891526 , RGD:4891522 , RGD:4891521 , RGD:4891528 , RGD:4891516 , RGD:4891519 , RGD:4891527
NCBI chr 2:203,867,771...203,873,965
Ensembl chr 2:203,853,888...203,873,965
G
CTNNA3
catenin alpha 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19187332
NCBI chr10:65,912,523...67,763,594
Ensembl chr10:65,912,457...67,763,637
G
CX3CL1
C-X3-C motif chemokine ligand 1
IEP
protein:increased expression:plasma
RGD
PMID:14657873
RGD:4891906
NCBI chr16:57,372,490...57,385,044
Ensembl chr16:57,372,477...57,385,044
G
CX3CR1
C-X3-C motif chemokine receptor 1
no_association
ISO IAGP
DNA:polymorphisms: :p.V249I, p.T280M (human) DNA:SNPs: :p.V249I, rs2669849 (human)
RGD
PMID:21037587 PMID:17505143 PMID:17082760
RGD:4891882 , RGD:4891904 , RGD:4891895
NCBI chr 3:39,263,494...39,292,966
Ensembl chr 3:39,263,495...39,281,735
G
CXCL1
C-X-C motif chemokine ligand 1
severity
IEP
RGD
PMID:20371397
RGD:5134983
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL10
C-X-C motif chemokine ligand 10
IEP ISO
protein:decreased expression:plasma
RGD
PMID:17302903 PMID:16602032 PMID:11994485
RGD:5135439 , RGD:5135457 , RGD:5135452
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
G
CXCL14
C-X-C motif chemokine ligand 14
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21150878
NCBI chr 5:135,570,679...135,578,991
Ensembl chr 5:135,570,679...135,579,279
G
CXCL2
C-X-C motif chemokine ligand 2
ISO
mRNA:increased expression:lung
RGD
PMID:20045013
RGD:5129686
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
CXCL5
C-X-C motif chemokine ligand 5
IEP ISO
mRNA:increased expression:bronchus epithelium
RGD
PMID:17234659 PMID:9620668
RGD:5135243 , RGD:5135265
NCBI chr 4:73,995,642...73,998,677
Ensembl chr 4:73,995,642...73,998,677
G
CXCL6
C-X-C motif chemokine ligand 6
ISO
RGD
PMID:9620668
RGD:5135265
NCBI chr 4:73,836,678...73,838,760
Ensembl chr 4:73,836,640...73,849,064
G
CXCL9
C-X-C motif chemokine ligand 9
ISO
RGD
PMID:15210824
RGD:5135447
NCBI chr 4:76,001,275...76,007,509
Ensembl chr 4:76,001,275...76,007,509
G
CXCR3
C-X-C motif chemokine receptor 3
susceptibility severity
ISO IAGP IEP
DNA:SNP:intron:IVS1+234G>A (human) protein:decreased expression:respiratory system fluid/secretion, T cell
RGD
PMID:18094012 PMID:16043121 PMID:16548899 PMID:17641057
RGD:4892088 , RGD:5143934 , RGD:5143932 , RGD:5135484
NCBI chr X:71,615,919...71,618,511
Ensembl chr X:71,615,916...71,618,511
G
CYBA
cytochrome b-245 alpha chain
susceptibility
IAGP
DNA:SNPs: :-930A>G, 242C>T, 640A>G (human) DNA:polymorphism: :-930A>G (human)
RGD
PMID:18716406 PMID:19459419
RGD:4772770 , RGD:4311041
NCBI chr16:88,643,289...88,651,053
Ensembl chr16:88,643,275...88,651,083
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
ISO
mRNA, protein:increased expression, decreased activity:lung
RGD
PMID:12415424
RGD:4892074
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
G
CYP2D6
cytochrome P450 family 2 subfamily D member 6 (gene/pseudogene)
IAGP
DNA:polymorphism: :1934G>A (human)
RGD
PMID:19575027
RGD:5143944
NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
IEP EXP ISO
mRNA:decreased expression:leukocyte CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:28807506 PMID:20514434 PMID:17081494
RGD:4892076 , RGD:4892220
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
G
CYSLTR1
cysteinyl leukotriene receptor 1
no_association severity
IAGP IMP ISO IEP
DNA:SNPs:promoter, exon:multiple (human) DNA:SNPs:promoter:-634C>T, -475A>C, -336A>G (human) DNA:SNP: :927T>C (human) mRNA, protein:increased expression:respiratory system mucosa
RGD
PMID:16771777 PMID:16630147 PMID:17153879 PMID:16776674 PMID:11591188 PMID:8087328 PMID:16387808 PMID:17689528 PMID:16123393 More...
RGD:4889116 , RGD:4784257 , RGD:4781742 , RGD:4782072 , RGD:4848936 , RGD:4888514 , RGD:4843543 , RGD:4781449 , RGD:4847129
NCBI chr X:78,271,468...78,327,611
Ensembl chr X:78,271,468...78,327,691
G
CYSLTR2
cysteinyl leukotriene receptor 2
IAGP
DNA:polymorphism: :601A>G (human) DNA:polymorphism: :-1220A>C (human)
RGD
PMID:15475736 PMID:15454733
RGD:5144002 , RGD:5144003
NCBI chr13:48,653,929...48,711,226
Ensembl chr13:48,653,711...48,711,226
G
DCN
decorin
ISO
RGD
PMID:16387756
RGD:2311423
NCBI chr12:91,140,484...91,182,817
Ensembl chr12:91,140,484...91,183,217
G
DEFB1
defensin beta 1
susceptibility
IAGP
DNA:SNP: :-1816 T>C (human) DNA:SNPs:5' utr:g.-52G>A, g.-44C>G, g.-20G>A (human)
RGD
PMID:15696078 PMID:16435024
RGD:4892263 , RGD:4892254
NCBI chr 8:6,870,592...6,877,936
Ensembl chr 8:6,870,592...6,877,936
G
DNAH5
dynein axonemal heavy chain 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21912604
NCBI chr 5:13,690,328...14,011,818
Ensembl chr 5:13,690,328...14,011,818
G
DNMT1
DNA methyltransferase 1
ISO EXP
DNA,mRNA:hypermethylation,decreased expression:promoter,respiratory tract: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23423710 PMID:23196709
RGD:9588646
NCBI chr19:10,133,346...10,194,953
Ensembl chr19:10,133,342...10,231,286
G
DPP10
dipeptidyl peptidase like 10
IAGP IEA ISO
DNA:SNPs (human) DNA:SNP: :rs10208402 (human) protein:increased expression:bronchus DNA:SNP:exon (human)
RGD GAD
PMID:21103062 PMID:19672052 PMID:15118671 PMID:17967935 PMID:14566338
RGD:4889866 , RGD:4892275 , RGD:1331525 , RGD:4892278 , RGD:4892276
NCBI chr 2:114,442,641...115,845,780
Ensembl chr 2:114,442,299...115,845,780
G
EBI3
Epstein-Barr virus induced 3
ISO
RGD
PMID:21255010
RGD:5128488
NCBI chr19:4,229,523...4,237,528
Ensembl chr19:4,229,523...4,237,528
G
EDN1
endothelin 1
IEP EXP IAGP
Severe Persistent Allergic Asthma; protein:increased secretion:lung (human) CTD Direct Evidence: marker/mechanism DNA:transition:intron:g.4124T>C (human)
CTD RGD
PMID:16981460 PMID:20588001 PMID:11668616
RGD:4144895 , RGD:4144869
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
G
EDNRA
endothelin receptor type A
ISO
RGD
PMID:17448648 PMID:18632188
RGD:4892322 , RGD:4892288
NCBI chr 4:147,481,097...147,544,954
Ensembl chr 4:147,480,917...147,544,954
G
EDNRB
endothelin receptor type B
IAGP ISO
DNA:polymorphism (human) mRNA:increased expression:bronchus, smooth muscle cell
RGD
PMID:17470272 PMID:15245576 PMID:18632188
RGD:4892321 , RGD:4892324 , RGD:4892288
NCBI chr13:77,895,487...77,975,527
Ensembl chr13:77,895,481...77,975,529
G
EGFR
epidermal growth factor receptor
severity
IEP ISO
protein:increased expression:bronchial epithelium (human) protein:increased expression:lung epithelium (rat) protein:increased expression:lung epithelium (mouse)
RGD
PMID:12580917 PMID:21224214 PMID:19954006 PMID:21072743
RGD:5131468 , RGD:5131633 , RGD:5131870 , RGD:5131642
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
G
EGR1
early growth response 1
IEP IAGP ISO
mRNA:increased expression:bronchoalveolar lavage cell (human) DNA:snp:5' utr:g.-4071A>G rs7729723 (human)
RGD
PMID:18774390 PMID:18507785 PMID:11254538
RGD:5130915 , RGD:5131993 , RGD:5131985
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
G
ELP1
elongator acetyltransferase complex subunit 1
no_association
IAGP
RGD
PMID:12774215 PMID:11281413
RGD:5129158 , RGD:5129157
NCBI chr 9:108,867,517...108,934,124
Ensembl chr 9:108,866,898...108,934,328
G
EPHX1
epoxide hydrolase 1
susceptibility
IAGP
DNA:SNPs:exons:p.Y113H (rs1051740), p.H139R (rs2234922) (human)
RGD
PMID:17711870
RGD:4889407
NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563
G
EPX
eosinophil peroxidase
severity disease_progression
IEP
protein:increased activity:sputum,nasal,pharyngeal mucosa
RGD
PMID:26645423 PMID:12199967 PMID:20813885
RGD:11574908 , RGD:13506892 , RGD:13506891
NCBI chr17:58,192,726...58,205,174
Ensembl chr17:58,192,726...58,205,174
G
ESR2
estrogen receptor 2
ISO
mRNA:decreased expression:lung (rat)
RGD
PMID:18375789
RGD:8694127
NCBI chr14:64,226,707...64,338,613
Ensembl chr14:64,084,232...64,338,112
G
F2
coagulation factor II, thrombin
IEP
protein:increased expression:plasma associated with Rhinosinusitis, associated with Nasal Polyps;protein:increased expression:nasal mucus
RGD
PMID:21658190 PMID:21711961
RGD:5147753 , RGD:5147783
NCBI chr11:46,719,213...46,739,506
Ensembl chr11:46,719,196...46,739,506
G
F2RL1
F2R like trypsin receptor 1
IDA
RGD
PMID:19864598
RGD:4892589
NCBI chr 5:76,819,030...76,835,315
Ensembl chr 5:76,818,933...76,835,315
G
F7
coagulation factor VII
treatment
ISO
RGD
PMID:24523826
RGD:11040539
NCBI chr13:113,105,788...113,120,685
Ensembl chr13:113,105,788...113,120,685
G
FAS
Fas cell surface death receptor
ISO
mRNA:increased expression:eosinophil
RGD
PMID:16337971
RGD:1600350
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
G
FCER1A
Fc epsilon receptor Ia
severity
IEP
Fatal asthma subjects Asthma symptoms persistent despite steroids
RGD
PMID:20937062 PMID:21388666
RGD:5128717 , RGD:5128711
NCBI chr 1:159,283,575...159,308,202
Ensembl chr 1:159,289,714...159,308,224
G
FCGR2A
Fc gamma receptor IIa
IEP
protein:increased expression:alveolar macrophage
RGD
PMID:9117017
RGD:5147982
NCBI chr 1:161,505,457...161,524,048
Ensembl chr 1:161,505,430...161,524,013
G
FCGR2B
Fc gamma receptor IIb
ISO
RGD
PMID:20179765
RGD:11344929
NCBI chr 1:161,647,243...161,678,654
Ensembl chr 1:161,663,143...161,678,654
G
FCGR3A
Fc gamma receptor IIIa
susceptibility
IAGP
DNA:polymorphism:exon:p.F158V(rs396991)(human)
RGD
PMID:18199088
RGD:5508449
NCBI chr 1:161,541,759...161,550,737
Ensembl chr 1:161,541,759...161,550,968
G
FGA
fibrinogen alpha chain
treatment
ISO
RGD
PMID:24523826
RGD:11040539
NCBI chr 4:154,583,126...154,590,742
Ensembl chr 4:154,583,126...154,590,742
G
FKBP5
FKBP prolyl isomerase 5
IAGP
ClinVar Annotator: match by term: Asthma
ClinVar
NCBI chr 6:35,573,590...35,728,583
Ensembl chr 6:35,573,585...35,728,583
G
FOXP3
forkhead box P3
treatment
EXP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:27965764 PMID:29317916 PMID:28944907 PMID:27633092
RGD:38549365 , RGD:38548920
NCBI chr X:49,250,438...49,264,710
Ensembl chr X:49,250,438...49,264,800
G
GATA3
GATA binding protein 3
ISO IEP
RGD
PMID:18186587 PMID:9949310
RGD:5128803 , RGD:5128802
NCBI chr10:8,045,333...8,075,198
Ensembl chr10:8,045,378...8,075,198
G
GC
GC vitamin D binding protein
ISO IEP
protein, mRNA:increased expression:bronchoalveolar lavage fluid:
RGD
PMID:21169467 PMID:21169467
RGD:5509920 , RGD:5509920
NCBI chr 4:71,741,693...71,805,520
Ensembl chr 4:71,741,696...71,804,041
G
GSDMB
gasdermin B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24241537
NCBI chr17:39,904,595...39,918,635
Ensembl chr17:39,904,595...39,919,854
G
GSTA1
glutathione S-transferase alpha 1
susceptibility
IAGP
DNA:polymorphism:promoter: -69C>T (human)
RGD
PMID:20374258
RGD:5490988
NCBI chr 6:52,791,371...52,803,816
Ensembl chr 6:52,791,371...52,803,860
G
GSTM1
glutathione S-transferase mu 1
resistance susceptibility
IAGP EXP
DNA:deletion: : CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16870661 PMID:18988661 PMID:17651144 PMID:21051083 PMID:11075422
RGD:4142509 , RGD:5490962 , RGD:4140921
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
G
GSTM3
glutathione S-transferase mu 3
IAGP IEP
DNA:polymorphism
RGD
PMID:11470996 PMID:17550934
RGD:5135039 , RGD:5135038
NCBI chr 1:109,733,937...109,741,038
Ensembl chr 1:109,733,932...109,741,038
G
GSTO2
glutathione S-transferase omega 2
susceptibility
IAGP
DNA:polymorphism:exon:p. N142D (human)
RGD
PMID:20374258
RGD:5490988
NCBI chr10:104,269,184...104,304,950
Ensembl chr10:104,268,873...104,304,950
G
GSTP1
glutathione S-transferase pi 1
no_association susceptibility disease_progression severity
IAGP EXP ISO
DNA:SNPs: :p.I105V, p.A114V (human) CTD Direct Evidence: marker/mechanism DNA:SNPs:exons:p.I105V (rs1695), A114V (rs1138272) (human) DNA:SNPs:intron,exon:(rs749174), (rs1138272)(human) DNA:polymorphism:exon:p.I105V (human) DNA:SNP: :p.A114V (human) DNA:polymorphism:exon:p.I105V (rs1695) (human)
CTD RGD
PMID:11994713 PMID:16870661 PMID:18988661 PMID:24117884 PMID:29411558 PMID:16176403 PMID:15693909 PMID:20210814 PMID:20858151 PMID:18057098 PMID:18709160 PMID:18787219 PMID:10806136 More...
RGD:4142519 , RGD:5490999 , RGD:5490991 , RGD:5490985 , RGD:4140951 , RGD:4140947 , RGD:4140946 , RGD:4142526
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
G
GSTT1
glutathione S-transferase theta 1
susceptibility
IAGP
DNA:deletion: :
RGD
PMID:15300848 PMID:21051083 PMID:11075422
RGD:4142539 , RGD:5490962 , RGD:4140921
G
HAVCR1
hepatitis A virus cellular receptor 1
IEP
RGD
PMID:20628202
RGD:5128851
NCBI chr 5:157,029,413...157,069,407
Ensembl chr 5:157,026,742...157,069,396
G
HAVCR2
hepatitis A virus cellular receptor 2
ISO
RGD
PMID:17517968
RGD:5135525
NCBI chr 5:157,085,832...157,109,044
Ensembl chr 5:157,085,422...157,142,869
G
HDAC2
histone deacetylase 2
IEP
mRNA:decreased expression:macrophage:
RGD
PMID:20538962
RGD:9590321
NCBI chr 6:113,933,028...113,971,148
Ensembl chr 6:113,933,028...114,011,308
G
HDC
histidine decarboxylase
IAGP
associated with Rhinitis;DNA:SNP: :p.E644D (rs2073440) (human)
RGD
PMID:20608921
RGD:5128884
NCBI chr15:50,241,947...50,265,726
Ensembl chr15:50,241,947...50,265,965
G
HIF1A
hypoxia inducible factor 1 subunit alpha
treatment
ISO
RGD
PMID:18160846
RGD:10402541
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
G
HLA-B
major histocompatibility complex, class I, B
susceptibility
IAGP
DNA:polymorphism:
RGD
PMID:28380482
RGD:13506910
NCBI chr 6:31,353,875...31,357,179
Ensembl chr 6:31,353,872...31,367,067
G
HLA-DPA1
major histocompatibility complex, class II, DP alpha 1
susceptibility
IAGP
DNA:polymorphism: :
RGD
PMID:21814517
RGD:13506911
NCBI chr 6:33,064,569...33,080,748
Ensembl chr 6:33,064,569...33,080,775
G
HLA-DPB1
major histocompatibility complex, class II, DP beta 1
susceptibility
IAGP EXP
DNA:haplotype DNA:polymorphisms: : CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16792590 PMID:17956852 PMID:21217921 PMID:21814517
RGD:5143938 , RGD:13506911
NCBI chr 6:33,075,990...33,089,696
Ensembl chr 6:33,075,936...33,089,696
G
HLA-DQA1
major histocompatibility complex, class II, DQ alpha 1
IAGP EXP
DNA:polymorphisms (human) CTD Direct Evidence: marker/mechanism DNA:polymorphism (human)
CTD RGD
PMID:10792356 PMID:12890388 PMID:10051703 PMID:11802952 PMID:19052351
RGD:5147799 , RGD:1331670 , RGD:5147831 , RGD:5147617
NCBI chr 6:32,637,406...32,655,272
Ensembl chr 6:32,628,179...32,647,062
G
HLA-DQA2
major histocompatibility complex, class II, DQ alpha 2
susceptibility
IAGP
DNA:polymorphism: :rs3916765(human)
RGD
PMID:20159242
RGD:13506913
NCBI chr 6:32,741,391...32,747,198
Ensembl chr 6:32,741,391...32,747,198
G
HLA-DQB1
major histocompatibility complex, class II, DQ beta 1
susceptibility disease_progression no_association
IAGP EXP
Alternaria sensitive asthma DNA:polymorphisms: : CTD Direct Evidence: marker/mechanism DNA:polymorphisms (human)
CTD RGD
PMID:10792356 PMID:20298583 PMID:20159242 PMID:20214848 PMID:23331206 PMID:11802952 PMID:12890388 PMID:19052351 More...
RGD:4144113 , RGD:13506913 , RGD:4144181 , RGD:13506906 , RGD:5147831 , RGD:5147799 , RGD:5147617
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
G
HLA-DRA
major histocompatibility complex, class II, DR alpha
susceptibility
IAGP
DNA:polymorphisms: :
RGD
PMID:20159242
RGD:13506913
NCBI chr 6:32,439,887...32,445,046
Ensembl chr 6:32,439,878...32,445,046
G
HLA-DRB1
major histocompatibility complex, class II, DR beta 1
susceptibility no_association severity
IAGP EXP
DNA:polymorphisms: : CTD Direct Evidence: marker/mechanism DNA:polymorphism (human)
CTD RGD
PMID:16792590 PMID:20214848 PMID:20159242 PMID:23331206 PMID:10051703 PMID:19439981 PMID:20486920 PMID:19528258 More...
RGD:4144181 , RGD:13506913 , RGD:13506906 , RGD:1331670 , RGD:5147663 , RGD:5147607 , RGD:4144196
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
G
HLA-DRB3
major histocompatibility complex, class II, DR beta 3
susceptibility
IAGP
RGD
PMID:22397267
RGD:13506905
G
HLA-G
major histocompatibility complex, class I, G
susceptibility
IAGP EXP
CTD Direct Evidence: marker/mechanism
CTD OMIM RGD
PMID:15611928
RGD:5144118
NCBI chr 6:29,826,474...29,831,021
Ensembl chr 6:29,826,967...29,831,125
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
IMP
RGD
PMID:20084838
RGD:5508450
NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001
G
HMOX1
heme oxygenase 1
severity
IEP EXP ISO
mRNA;protein:increased expression:Leukocytes, Mononuclear CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18048809 PMID:16196283 PMID:20596599
RGD:4145408 , RGD:4145403
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HNMT
histamine N-methyltransferase
no_association susceptibility
IAGP EXP
ClinVar Annotator: match by term: Asthma, susceptibility to CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD RGD
PMID:10752634 PMID:10803682 PMID:16205835 PMID:17651147 PMID:25741868 PMID:17651147 PMID:10803682 PMID:21040557 PMID:15693910 PMID:16205835 More...
RGD:5128885 , RGD:5128881 , RGD:5128883 , RGD:5128888 , RGD:5128887
NCBI chr 2:137,964,473...138,016,364
Ensembl chr 2:137,964,020...138,016,364
G
HP
haptoglobin
IEP
RGD
PMID:21471098 PMID:21169467
RGD:5144151 , RGD:5509920
NCBI chr16:72,054,505...72,061,055
Ensembl chr16:72,054,505...72,061,055
G
HSD11B2
hydroxysteroid 11-beta dehydrogenase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:11932298
NCBI chr16:67,429,801...67,437,553
Ensembl chr16:67,430,652...67,437,553
G
HTR2A
5-hydroxytryptamine receptor 2A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25322896
NCBI chr13:46,831,546...46,898,082
Ensembl chr13:46,831,546...46,897,076
G
ICAM1
intercellular adhesion molecule 1
ISO EXP IEP
mRNA:increased expression:aorta (mouse) CTD Direct Evidence: marker/mechanism protein:increased expression:lung, serum (rat) protein:increased secretion:lung (human)
CTD RGD
PMID:17014439 PMID:25003170 PMID:20400685 PMID:20953388 PMID:20205697
RGD:4145444 , RGD:4145331 , RGD:4145509
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
IFNG
interferon gamma
treatment resistance
IEP ISO IEA
protein:increased expression:sputum
RGD GAD
PMID:20817868 PMID:12396623 PMID:15118671 PMID:20953328 PMID:19542437
RGD:4145651 , RGD:10755706 , RGD:1331525 , RGD:4145525 , RGD:5128479
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IFNGR1
interferon gamma receptor 1
ISO IAGP
DNA: SNP: Leu467Pro
RGD
PMID:21737883 PMID:12851715
RGD:6480255 , RGD:6480431
NCBI chr 6:137,197,484...137,219,385
Ensembl chr 6:137,197,483...137,219,449
G
IFNL1
interferon lambda 1
exacerbates
IEP
associated with common cold;mRNA:decreased expression:sputum (human) associated with common cold;protein:increased expression: nasal cavity (human)
RGD
PMID:25784275 PMID:22135341
RGD:126848770 , RGD:126848775
NCBI chr19:39,296,407...39,298,673
Ensembl chr19:39,296,407...39,298,673
G
IFNL3
interferon lambda 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22295096
NCBI chr19:39,243,455...39,245,250
Ensembl chr19:39,243,455...39,245,250
G
IKZF3
IKAROS family zinc finger 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25256354
NCBI chr17:39,757,715...39,864,312
Ensembl chr17:39,757,715...39,864,312
G
IL10
interleukin 10
treatment susceptibility
ISO EXP IAGP IEP
CTD Direct Evidence: marker/mechanism DNA:polymorphism: :-627C>A (human) protein:decreased expression:plasma
CTD RGD
PMID:29317916 PMID:20560982 PMID:21998459 PMID:12938145 PMID:20237464 PMID:20230687 PMID:20644177 PMID:20121766 More...
RGD:5131623 , RGD:11046261 , RGD:4143221 , RGD:4140471 , RGD:4140421 , RGD:4140459 , RGD:4140451
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL12A
interleukin 12A
ISO
RGD
PMID:17056578 PMID:17548618
RGD:4438438 , RGD:4373570
NCBI chr 3:159,988,835...159,996,019
Ensembl chr 3:159,988,835...159,996,019
G
IL12B
interleukin 12B
severity susceptibility
IAGP
DNA:polymorphisms:introns: ClinVar Annotator: match by term: Asthma, susceptibility to DNA:polymorphism:promoter DNA:polymorphisms:promoter, 3'utr:
ClinVar RGD
PMID:15322986 PMID:15322986 PMID:12241719 PMID:16210052
RGD:1600043 , RGD:4145428 , RGD:4145438
NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
G
IL13
interleukin 13
susceptibility severity no_association
IAGP EXP IEP ISO
DNA:polymorphism:promoter:c. -1055C>T (human) ClinVar Annotator: match by term: Asthma, susceptibility to CTD Direct Evidence: marker/mechanism associated with Dermatitis, Atopic;DNA, protein:SNP, increased expression:promoter, serum:-1112C>T (human) DNA:polymorphism: :-1512A>C, -1112C>T, 2044G>A (human) protein:increased expression:serum DNA:polymorphism:3'utr:c.4738G>A (human) DNA:polymorphism: :c. 2044G>A (human) mRNA, protein:increased expression:esophagus, Bronchoalveolar Lavage Fluid DNA:polymorphisms:promoters,exon4: rs1881457, rs1800925, rs20541 (human) DNA:polymorphism: :p. R110Q (human) DNA:polymorphism: :c. 1923C>T (human) DNA:SNP: :c. -646A>G (human) DNA:polymorphisms: :rs20541, rs1295685(human) DNA:polymorphism: :c.-1055C>T (human) DNA:polymorphism:cds:p.R130Q (human) protein:increased expression:sputum
ClinVar OMIM CTD RGD
PMID:10699178 PMID:11588017 PMID:11709756 PMID:12847555 PMID:12928861 PMID:15356556 PMID:15483090 PMID:15711639 PMID:15879126 PMID:22867017 PMID:16024972 PMID:23317483 PMID:17006604 PMID:11758895 PMID:12604708 PMID:11588017 PMID:18341619 PMID:20819635 PMID:16393274 PMID:18222984 PMID:18258919 PMID:19796199 PMID:12091879 PMID:15315330 PMID:19575932 PMID:17303794 PMID:20484924 PMID:20198887 PMID:11678850 PMID:18328894 PMID:16120094 More...
RGD:4220633 , RGD:8549509 , RGD:4892639 , RGD:4763153 , RGD:2301686 , RGD:4765128 , RGD:4145776 , RGD:4145453 , RGD:4145508 , RGD:2307110 , RGD:4145639 , RGD:4145601 , RGD:4145664 , RGD:4321828 , RGD:4145775 , RGD:4146241 , RGD:4145534 , RGD:4145593 , RGD:4763761 , RGD:4145777 , RGD:4206706
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
G
IL13RA1
interleukin 13 receptor subunit alpha 1
no_association
ISO IAGP
DNA:polymorphisms:promoter, 3' utr:-281T>G, 1365A>G (human) mRNA:increased expression:bronchus DNA:polymorphism: :1398A>G (human) DNA:polymorphism: :1050C>T (human)
RGD
PMID:11714828 PMID:18480254 PMID:17392323 PMID:20383033 PMID:17006604 PMID:10686479 More...
RGD:4892654 , RGD:4892647 , RGD:4892650 , RGD:4892646 , RGD:4892639 , RGD:4892655
NCBI chr X:118,727,606...118,805,228
Ensembl chr X:118,727,133...118,794,535
G
IL13RA2
interleukin 13 receptor subunit alpha 2
ISO IEP
mRNA:increased expression:bronchus protein:increased expression:serum
RGD
PMID:20383033 PMID:21462799 PMID:17885690
RGD:4892646 , RGD:8549521 , RGD:4892649
NCBI chr X:115,003,982...115,017,616
Ensembl chr X:115,003,975...115,019,977
G
IL15
interleukin 15
no_association
IAGP ISO
DNA:SNPs: :multiple (human)
RGD
PMID:19133918 PMID:16629787 PMID:11160248 PMID:15843549 PMID:15131572
RGD:5000760 , RGD:4984421 , RGD:4990462 , RGD:5000757 , RGD:5000758
NCBI chr 4:141,636,583...141,733,987
Ensembl chr 4:141,636,583...141,733,987
G
IL16
interleukin 16
no_association severity
IAGP IEP ISO
DNA:SNP:promoter:-295T>C (human) associated with Rhinitis;protein:increased expression:respiratory system fluid/secretion protein:increased expression:serum
RGD
PMID:15784111 PMID:16734115 PMID:12872394 PMID:10585533 PMID:16387589
RGD:5024935 , RGD:5024928 , RGD:5024930 , RGD:5024937 , RGD:5024934
NCBI chr15:81,182,712...81,314,058
Ensembl chr15:81,159,575...81,314,058
G
IL17A
interleukin 17A
susceptibility
IEP ISO IAGP
protein:increased expression:sputum DNA:SNP:promoter:rs2275913 (human) protein:increased expression:alveolar macrophage mRNA,protein:increased expression:Leukocytes, Mononuclear, lung, serum
RGD
PMID:15730730 PMID:20351038 PMID:20437253 PMID:18941201 PMID:18060619
RGD:4889114 , RGD:4888527 , RGD:4889139 , RGD:4889152 , RGD:4839043
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
IL17RB
interleukin 17 receptor B
ISO
associated with Picornaviridae Infections
RGD
PMID:25273095
RGD:39128256
NCBI chr 3:53,846,568...53,865,794
Ensembl chr 3:53,846,568...53,865,794
G
IL18
interleukin 18
severity susceptibility disease_progression
IAGP ISO IMP IEP
DNA:SNPs:Promoter:c. -607C>A (rs1946518), -137G/C (rs187238) (human) DNA:SNP:promoter:c.and -137G>C (rs187238)(human) DNA:polymorphism: :c. -105A>C (human) DNA:SNP:promoter: c.-380C>G (rs5744247)(human) protein:increased expression:serum
RGD
PMID:17767553 PMID:18826499 PMID:20497957 PMID:20497957 PMID:16433859 PMID:18200581 PMID:19745201 PMID:11174201 More...
RGD:4889585 , RGD:4889908 , RGD:4889898 , RGD:4889898 , RGD:4889923 , RGD:4889910 , RGD:4889900 , RGD:4889863
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,251...112,164,096
G
IL18R1
interleukin 18 receptor 1
IAGP ISO
DNA:SNPs: :multiple (human) DNA:SNP: :rs3771166 (human)
RGD
PMID:18774397 PMID:19910030 PMID:20860503 PMID:11972614 PMID:18382474
RGD:5024946 , RGD:5024945 , RGD:5024942 , RGD:5024948 , RGD:5024947
NCBI chr 2:102,355,796...102,398,776
Ensembl chr 2:102,311,529...102,398,777
G
IL19
interleukin 19
IEP
protein:increased expression:serum
RGD
PMID:15557163
RGD:5037236
NCBI chr 1:206,770,773...206,842,981
Ensembl chr 1:206,770,764...206,842,981
G
IL1A
interleukin 1 alpha
IAGP
DNA:polymorphisms: :
RGD
PMID:18763028
RGD:4142802
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
IL1B
interleukin 1 beta
susceptibility
IAGP EXP ISO IEP
DNA:polymorphism: :-511C>T (human) CTD Direct Evidence: marker/mechanism protein:decreased expression:neutrophil
CTD RGD
PMID:9176529 PMID:18926055 PMID:19684087 PMID:19842845
RGD:4142864 , RGD:4142836 , RGD:4142830
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1RL1
interleukin 1 receptor like 1
susceptibility severity
ISO EXP IAGP IEP
protein:increased expression:serum CTD Direct Evidence: marker/mechanism DNA:SNP: :rs1420101 (human) DNA:SNPs:intron:rs1420089, rs1861245,rs1946131 (human) DNA:SNP: :rs10197862 (human) DNA:SNP: :rs1041973 (human)
CTD RGD
PMID:19198610 PMID:21150878 PMID:21804549 PMID:24241537 PMID:27472835 PMID:17623648 PMID:17407196 PMID:19179489 PMID:19198610 PMID:19852851 PMID:21150878 PMID:21281963 PMID:11463601 More...
RGD:5144235 , RGD:5144245 , RGD:5144244 , RGD:5144243 , RGD:5144242 , RGD:5144240 , RGD:5144239 , RGD:5144237
NCBI chr 2:102,311,563...102,352,356
Ensembl chr 2:102,311,502...102,352,037
G
IL1RN
interleukin 1 receptor antagonist
severity susceptibility
IEP EXP IAGP IMP
protein:increased expression:plasma CTD Direct Evidence: marker/mechanism DNA:polymorphism:intron (human) DNA:SNP: :rs2234678 (human) DNA:SNPs: :rs447713, rs3087271 (human) DNA:SNPs: :multiple (human) DNA, protein:repeat, decreased expression (human)
CTD RGD
PMID:9176529 PMID:10843772 PMID:18926055 PMID:17107994 PMID:16409203 PMID:16724092 PMID:15020290 PMID:18763028 PMID:11027520 More...
RGD:4143225 , RGD:4142864 , RGD:4143208 , RGD:4143163 , RGD:4143209 , RGD:4143216 , RGD:4142802 , RGD:4143224
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
IL2
interleukin 2
susceptibility
IEP IAGP
DNA:SNP:promoter:rs2069762(human)
RGD
PMID:20926789 PMID:16333313
RGD:4889118 , RGD:8663473
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
G
IL21
interleukin 21
IAGP
DNA:SNP:exon:5250C>T (human)
RGD
PMID:18802358
RGD:5147396
NCBI chr 4:122,610,108...122,621,066
Ensembl chr 4:122,610,108...122,621,066
G
IL22
interleukin 22
treatment severity
ISO IEP
mRNA:increased expression:blood, mononuclear cell protein:increased expression:serum
RGD
PMID:21789181 PMID:21998459 PMID:21535180 PMID:21297073
RGD:5147401 , RGD:11046261 , RGD:5147409 , RGD:5147403
NCBI chr12:68,248,242...68,253,604
Ensembl chr12:68,248,242...68,253,604
G
IL23R
interleukin 23 receptor
ISO
RGD
PMID:19935773
RGD:5037240
NCBI chr 1:67,138,637...67,265,903
Ensembl chr 1:67,138,907...67,259,979
G
IL25
interleukin 25
ISO
mRNA, protein:increased expression:lung
RGD
PMID:25273095
RGD:39128256
NCBI chr14:23,372,809...23,376,403
Ensembl chr14:23,372,809...23,376,403
G
IL27
interleukin 27
susceptibility treatment
IAGP ISO IEP
DNA:SNP: :g.-964A>G (human) protein:increased expression:sputum
RGD
PMID:17318299 PMID:26595888 PMID:17878337 PMID:20817868 PMID:19542437
RGD:5128485 , RGD:11076728 , RGD:5128491 , RGD:4145651 , RGD:5128479
NCBI chr16:28,499,362...28,506,834
Ensembl chr16:28,499,362...28,512,051
G
IL27RA
interleukin 27 receptor subunit alpha
ISO
RGD
PMID:16081811
RGD:5128496
NCBI chr19:14,031,762...14,053,218
Ensembl chr19:14,031,762...14,053,218
G
IL2RA
interleukin 2 receptor subunit alpha
ISO
RGD
PMID:21377197 PMID:20525707
RGD:5147437 , RGD:5147445
NCBI chr10:6,010,689...6,062,367
Ensembl chr10:6,010,689...6,062,370
G
IL2RB
interleukin 2 receptor subunit beta
IAGP ISO
DNA:SNP: :rs2284033 (human)
RGD
PMID:20860503 PMID:18641329
RGD:5024942 , RGD:5147447
NCBI chr22:37,125,838...37,175,118
Ensembl chr22:37,118,666...37,175,118
G
IL3
interleukin 3
susceptibility
IAGP
DNA:SNP: :rs40401(human) DNA:polymorphism:cds:+79T>C(S27P)(human)
RGD
PMID:24684517 PMID:15372320
RGD:13506914 , RGD:13506916
NCBI chr 5:132,060,655...132,063,204
Ensembl chr 5:132,060,655...132,063,204
G
IL32
interleukin 32
IEP
protein:increased expression:blood serum (human)
RGD
PMID:22336080
RGD:150340749
NCBI chr16:3,065,403...3,069,530
Ensembl chr16:3,065,297...3,082,192
G
IL33
interleukin 33
treatment severity
EXP ISO IEP
CTD Direct Evidence: marker/mechanism associated with viral pneumonia; associated with fungal infectious disease
CTD RGD
PMID:19198610 PMID:21804549 PMID:24241537 PMID:27472835 PMID:29067999 PMID:28947081 PMID:25746970 More...
RGD:39939002 , RGD:39938968
NCBI chr 9:6,215,149...6,257,983
Ensembl chr 9:6,215,786...6,257,983
G
IL4
interleukin 4
treatment no_association
IAGP EXP ISO IEP
DNA:polymorphism (human) CTD Direct Evidence: marker/mechanism mRNA, protein:increase expression:leukocyte, serum protein:increased expression:lung DNA:SNP: :589C>T (human) mRNA:increased expression:lung, spleen protein:increased expression:respiratory system fluid/secretion
CTD RGD
PMID:18357729 PMID:21103062 PMID:24946644 PMID:24450480 PMID:18211752 PMID:20524005 PMID:21364926 PMID:21354484 PMID:21375458 More...
RGD:4889866 , RGD:10402799 , RGD:10402791 , RGD:2317290 , RGD:5128560 , RGD:5128500 , RGD:5128502 , RGD:5128557
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
IL4R
interleukin 4 receptor
susceptibility severity disease_progression
ISO ISS IAGP IDA IEP
DNA:mutation:cds:p.Q576R (mouse) OMIM:600807 DNA:polymorphism:promoter:c.-3223C>T (human) DNA:SNPs:cds:p. I75V, Q576R (human) DNA:polymorphism:cds:p.I50V (human) DNA:polymorphism:cds:p.Q551R (human) DNA:polymorphism::-1902G/A (human) DNA:SNPs: :multiple protein:increased secretion:plasma DNA:polymorphism:cds:p.Q576R (human) DNA:polymorphism:cds:p. S478P (human) DNA:SNPs:cds:p.E375A, Q551R (human)
MouseDO RGD
PMID:19770271 PMID:15479272 PMID:12133990 PMID:18425216 PMID:17586032 PMID:11398072 PMID:20868478 PMID:17823973 PMID:15479272 PMID:12940513 PMID:20953944 PMID:11709756 PMID:20605987 PMID:16917945 PMID:17170387 More...
RGD:4890003 , RGD:4890351 , RGD:4890404 , RGD:4890346 , RGD:4890348 , RGD:4890406 , RGD:4890387 , RGD:4890347 , RGD:4890351 , RGD:4890402 , RGD:5128514 , RGD:4890024 , RGD:5128553 , RGD:4890352 , RGD:4890349
NCBI chr16:27,313,756...27,364,778
Ensembl chr16:27,313,668...27,364,778
G
IL5
interleukin 5
treatment disease_progression
ISO EXP IEP IAGP IDA
CTD Direct Evidence: marker/mechanism protein:increased expression:lungs, respiratory system fluid/secretion protein: increased levels: sputum protein:increased expression:respiratory system fluid/secretion DNA:polymorphism:promoter:-703C>T (human)
CTD RGD
PMID:7540862 PMID:23266719 PMID:19947994 PMID:25008888 PMID:11159041 PMID:22085848 PMID:22186238 PMID:9493449 PMID:15626484 PMID:9182686 PMID:17074272 PMID:18629290 PMID:15502111 More...
RGD:4890938 , RGD:11354973 , RGD:5687189 , RGD:5687144 , RGD:5687140 , RGD:4890962 , RGD:4890947 , RGD:4890963 , RGD:4145461 , RGD:4890940 , RGD:4890948
NCBI chr 5:132,541,445...132,556,815
Ensembl chr 5:132,541,445...132,556,838
G
IL5RA
interleukin 5 receptor subunit alpha
IAGP ISO IEP IMP
DNA:SNPs (human) DNA:SNP: :c.25091G>A (human)
RGD
PMID:16217591 PMID:17276963 PMID:20592918 PMID:10224351 PMID:20513521 PMID:10848907 More...
RGD:5128626 , RGD:5128617 , RGD:5128614 , RGD:5128623 , RGD:5128625 , RGD:5128627
NCBI chr 3:3,066,324...3,110,374
Ensembl chr 3:3,066,324...3,126,613
G
IL6
interleukin 6
IEP EXP ISO
associated with Hypersensitivity;protein:increased expression:sputum CTD Direct Evidence: marker/mechanism protein:increased expression:lung
CTD RGD
PMID:29902480 PMID:20816188 PMID:20840469 PMID:20658762 PMID:21115736
RGD:4143266 , RGD:4143265 , RGD:4143271 , RGD:5128630
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IL6R
interleukin 6 receptor
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:29902480 PMID:17496315 PMID:21115736
RGD:5128662 , RGD:5128630
NCBI chr 1:154,405,343...154,469,450
Ensembl chr 1:154,405,193...154,469,450
G
IL9
interleukin 9
ISO IMP IEP
protein:increased expression:respiratory system fluid/secretion protein:increased expression:sputum, macrophage, cytoplasm
RGD
PMID:12153980 PMID:21356110 PMID:15531759 PMID:17446528 PMID:15303135
RGD:5128700 , RGD:5128707 , RGD:5128690 , RGD:5128686 , RGD:5128691
NCBI chr 5:135,892,246...135,895,841
Ensembl chr 5:135,892,246...135,895,841
G
IL9R
interleukin 9 receptor
IEP
RGD
PMID:10629460
RGD:5128704
NCBI chr X:155,997,696...156,013,020 NCBI chr Y:57,184,072...57,197,869
Ensembl chr X:155,997,696...156,013,017 Ensembl chr Y:155,997,696...156,013,017
G
IRAK3
interleukin 1 receptor associated kinase 3
susceptibility
IAGP
ClinVar Annotator: match by term: Asthma-related traits, susceptibility to, 5
OMIM ClinVar
PMID:17503328
NCBI chr12:66,189,214...66,254,622
Ensembl chr12:66,189,195...66,254,622
G
IRF1
interferon regulatory factor 1
no_association susceptibility
IAGP IEP
DNA:polymorphisms:promoter, cds:-300G>T, 4396A>G, 6355G>A (human) protein:increased expression:respiratory tract epithelium DNA:repeat:intron (human)
RGD
PMID:11069564 PMID:10225979 PMID:16961714
RGD:5128726 , RGD:5128723 , RGD:5128724
NCBI chr 5:132,481,609...132,490,773
Ensembl chr 5:132,440,440...132,508,719
G
IRF3
interferon regulatory factor 3
ISO
RGD
PMID:20673978
RGD:5128793
NCBI chr19:49,659,572...49,665,857
Ensembl chr19:49,659,569...49,665,875
G
ITGB3
integrin subunit beta 3
IAGP
DNA:SNPs: :
RGD
PMID:17556058
RGD:5037230
NCBI chr17:47,253,827...47,313,743
Ensembl chr17:47,253,827...47,313,743
G
ITGB6
integrin subunit beta 6
ISS
OMIM:600807
MouseDO
NCBI chr 2:160,099,671...160,200,272
Ensembl chr 2:160,099,667...160,271,888
G
ITPR1
inositol 1,4,5-trisphosphate receptor type 1
ISO
RGD
PMID:21777465
RGD:5147661
NCBI chr 3:4,493,348...4,847,506
Ensembl chr 3:4,493,345...4,847,506
G
KDR
kinase insert domain receptor
ISO IEP
associated with Rhinitis,Allergic,Seasonal;protein:increased expression:nasal cavity of mucosa:
RGD
PMID:20921519 PMID:17651148
RGD:5684385 , RGD:8551771
NCBI chr 4:55,078,481...55,125,595
Ensembl chr 4:55,078,481...55,125,595
G
KIF3A
kinesin family member 3A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21912604
NCBI chr 5:132,688,812...132,737,546
Ensembl chr 5:132,692,628...132,737,638
G
KRT19
keratin 19
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15478392
NCBI chr17:41,523,617...41,528,308
Ensembl chr17:41,523,617...41,528,308
G
LEP
leptin
IEP
protein:increased expression:plasma
RGD
PMID:19705789
RGD:5128781
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
G
LGALS3
galectin 3
treatment
IMP
RGD
PMID:16424226
RGD:9685213
NCBI chr14:55,129,252...55,145,430
Ensembl chr14:55,124,110...55,145,423
G
LOC129994952
ATAC-STARR-seq lymphoblastoid silent region 16492
IAGP
ClinVar Annotator: match by term: Beta-2-adrenoreceptor agonist, reduced response to
ClinVar
PMID:16596417
NCBI chr 5:148,826,740...148,826,879
G
LTA
lymphotoxin alpha
susceptibility no_association
IAGP
DNA:polymorphisms:promoter DNA:polymorphism:intron
RGD
PMID:15969671 PMID:18947013 PMID:12530118 PMID:17536219
RGD:4143373 , RGD:4143370 , RGD:4143254 , RGD:4143371
NCBI chr 6:31,560,610...31,574,324
Ensembl chr 6:31,572,054...31,574,324
G
LTA4H
leukotriene A4 hydrolase
ISO
mRNA:increased expression:lung, cerebral cortex (rat)
RGD
PMID:15715933
RGD:2316607
NCBI chr12:96,000,753...96,043,520
Ensembl chr12:96,000,753...96,043,520
G
MBL2
mannose binding lectin 2
susceptibility
IAGP
associated with Bronchiolitis;DNA:polymorphism:exon: DNA:SNP:cds:p.G54D(human)
RGD
PMID:22512728 PMID:22674410
RGD:8693709 , RGD:12910828
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
G
MEFV
MEFV innate immunity regulator, pyrin
susceptibility
IAGP
DNA:mutations:exons
RGD
PMID:18219832
RGD:5129186
NCBI chr16:3,242,027...3,256,633
Ensembl chr16:3,242,027...3,256,633
G
MIF
macrophage migration inhibitory factor
severity
IAGP ISO IEP
DNA:SNP:promoter:rs755622(human) protein:increased expression:bronchoalveolar lavage fluid DNA:repeats:promoter
RGD
PMID:19317738 PMID:17373669 PMID:9637721 PMID:16455830 PMID:16186482
RGD:4891059 , RGD:4891035 , RGD:4891043 , RGD:1641985 , RGD:4891052
NCBI chr22:23,894,383...23,895,223
Ensembl chr22:23,894,383...23,895,227
G
MMP1
matrix metallopeptidase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24469321
NCBI chr11:102,789,919...102,798,160
Ensembl chr11:102,789,401...102,798,160
G
MMP10
matrix metallopeptidase 10
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16926187
NCBI chr11:102,770,502...102,780,628
Ensembl chr11:102,770,502...102,780,628
G
MMP9
matrix metallopeptidase 9
IEP EXP IMP IAGP ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism DNA:SNP: : rs2664538(human) mRNA, protein:increased expression:lung
CTD RGD
PMID:11742282 PMID:15131573 PMID:21439806 PMID:19940022 PMID:20181264 PMID:16191269 PMID:19361849 More...
RGD:5129204 , RGD:5129522 , RGD:5130859 , RGD:2325953 , RGD:5129687
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MPO
myeloperoxidase
susceptibility
IEP IAGP
protein:increased expression:serum DNA:polymorphism: :−463G > A (human)
RGD
PMID:10731862 PMID:19544176
RGD:5130994 , RGD:5130989
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
G
MS4A2
membrane spanning 4-domains A2
susceptibility
IAGP
DNA:SNPs:multiple:, rs573790, rs2583476, rs569108 DNA:SNPs: : rs556917, rs502581, rs502419 (human) Atopy and bronchial hyperresponsiveness, OMIM:147050 DNA:polymorphism:CDS:amino acid E237G DNA:SNP: : -109C>T (human)
RGD
PMID:19218813 PMID:21320344 PMID:8817330 PMID:19862939
RGD:5131151 , RGD:5131149 , RGD:1599903 , RGD:5131092
NCBI chr11:60,088,259...60,098,467
Ensembl chr11:60,088,261...60,098,467
G
MTHFR
methylenetetrahydrofolate reductase
IAGP
DNA:transition:cds:g.677C>T (human)
RGD
PMID:20456312
RGD:4891145
NCBI chr 1:11,785,723...11,805,964
Ensembl chr 1:11,785,723...11,806,455
G
MUC1
mucin 1, cell surface associated
IEP
protein:increased expression:serum
RGD
PMID:11802251
RGD:5131281
NCBI chr 1:155,185,824...155,192,915
Ensembl chr 1:155,185,824...155,192,916
G
MUC2
mucin 2, oligomeric mucus/gel-forming
IAGP ISO
associated with hypersensitivity
RGD
PMID:11062147 PMID:14594655
RGD:5131178 , RGD:7349354
NCBI chr11:1,074,874...1,110,508
Ensembl chr11:1,074,875...1,110,511
G
MUC5AC
mucin 5AC, oligomeric mucus/gel-forming
treatment
IEP ISO
protein:increased expression:lung mRNA, protein:increased expression:lung mRNA,protein:increased expression:lung
RGD
PMID:17698377 PMID:21549818 PMID:21780541 PMID:14594655 PMID:17590487
RGD:5131204 , RGD:7364729 , RGD:7349407 , RGD:7349354 , RGD:2324962
NCBI chr11:1,157,953...1,201,138
Ensembl chr11:1,157,953...1,201,138
G
MUC5B
mucin 5B, oligomeric mucus/gel-forming
IEP ISO
protein:altered expression:sputum
RGD
PMID:11802783 PMID:11587997
RGD:5131252 , RGD:7364763
NCBI chr11:1,223,066...1,262,172
Ensembl chr11:1,223,066...1,262,172
G
MUC7
mucin 7, secreted
IAGP EXP
ClinVar Annotator: match by term: Asthma, protection against CTD Direct Evidence: marker/mechanism
ClinVar CTD OMIM
PMID:11378823 PMID:16759176 PMID:28492532
NCBI chr 4:70,430,492...70,482,997
Ensembl chr 4:70,430,492...70,482,997
G
MYB
MYB proto-oncogene, transcription factor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19198610
NCBI chr 6:135,181,308...135,219,172
Ensembl chr 6:135,181,308...135,219,173
G
MYD88
MYD88 innate immune signal transduction adaptor
ameliorates
ISO
RGD
PMID:26882889
RGD:11531666
NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,552...38,143,024
G
MYLK
myosin light chain kinase
IAGP
RGD
PMID:17472811
RGD:4891492
NCBI chr 3:123,610,049...123,884,332
Ensembl chr 3:123,610,049...123,884,332
G
NAT2
N-acetyltransferase 2
susceptibility
IAGP
Asthma, Aspirin-Induced; DNA:polymorphism: : DNA:polymorphisms: :
RGD
PMID:20602614 PMID:16924569
RGD:5131600 , RGD:5131606
NCBI chr 8:18,386,301...18,401,218
Ensembl chr 8:18,391,282...18,401,218
G
NFE2L2
NFE2 like bZIP transcription factor 2
severity
IEP
mRNA:increased expression:bronchoalveolar lavage cell, peripheral blood mononuclear cell (human)
RGD
PMID:21514635
RGD:6893376
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
G
NGF
nerve growth factor
severity
IDA IEP ISO
protein:increased expression:lung, serum protein:increased expression:blood, eosinophil
RGD
PMID:11737043 PMID:17164945 PMID:17497413 PMID:12752594
RGD:4891123 , RGD:4891108 , RGD:4891068 , RGD:4891122
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
G
NGFR
nerve growth factor receptor
ISO
RGD
PMID:16603479 PMID:12540484
RGD:5144070 , RGD:5144072
NCBI chr17:49,495,293...49,515,008
Ensembl chr17:49,495,293...49,515,008
G
NOD1
nucleotide binding oligomerization domain containing 1
susceptibility
IAGP
DNA:SNP: :rs2075817 (human) DNA:insertion:cds:
RGD
PMID:16918516 PMID:15718249
RGD:5131519 , RGD:5131518
NCBI chr 7:30,424,527...30,478,784
Ensembl chr 7:30,424,527...30,478,784
G
NOD2
nucleotide binding oligomerization domain containing 2
susceptibility
IAGP ISO
DNA:polymorphisms:intron, exon/3'UTR (rs1077861, rs3135500) (human)
RGD
PMID:16008671 PMID:21051079
RGD:5131477 , RGD:5508757
NCBI chr16:50,693,606...50,733,075
Ensembl chr16:50,693,588...50,733,077
G
NOS1
nitric oxide synthase 1
susceptibility
IAGP
DNA:repeats: : DNA:repeats:intron DNA:repeats:exon
RGD
PMID:10673365 PMID:20609134 PMID:14767694 PMID:10833424
RGD:5132869 , RGD:5132863 , RGD:5132615 , RGD:5132860
NCBI chr12:117,208,142...117,361,626
Ensembl chr12:117,208,142...117,452,170
G
NOS2
nitric oxide synthase 2
disease_progression no_association severity
ISO EXP IEP IAGP
protein:increased expression:lung, bronchoalveolar lavage fluid CTD Direct Evidence: marker/mechanism protein:increased expression, increased activity:lung (rat) associated with Rhinitis, Allergic, Seasonal; protein:increased expression:nasal mucosa DNA:repeat:promoter DNA:repeats:promoter mRNA:increased expression:monocyte DNA:repeats:promoter, introns (human) DNA:SNP:exon:p.S608L (human)
CTD RGD
PMID:19800904 PMID:17161822 PMID:21847581 PMID:18254476 PMID:16703578 PMID:18714530 PMID:20842520 PMID:16540403 PMID:17189532 PMID:17177683 PMID:20841959 More...
RGD:4891927 , RGD:5509073 , RGD:4891910 , RGD:4891953 , RGD:4891508 , RGD:4891419 , RGD:4891957 , RGD:4891924 , RGD:4891925 , RGD:4891480
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NOS3
nitric oxide synthase 3
susceptibility
IAGP
DNA:repeats:intron DNA:polymorphisms:promoter:c. -786C>T, -691C>T (human) DNA:snps, repeat, haplotype:promoter, introns, exons:multiple (human)
RGD
PMID:16081038 PMID:16837812 PMID:18486767
RGD:4892062 , RGD:4892058 , RGD:4892053
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
G
NPSR1
neuropeptide S receptor 1
susceptibility
IAGP EXP
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Asthma-related traits, susceptibility to, 2
OMIM CTD ClinVar RGD
PMID:15073379 PMID:15710598 PMID:15764725 PMID:16926187 PMID:17702965 PMID:15073379 PMID:18285428 More...
RGD:4891923 , RGD:4891921 , RGD:4891922
NCBI chr 7:34,658,218...34,878,332
Ensembl chr 7:34,658,218...34,878,332
G
NPSR1-AS1
NPSR1 antisense RNA 1
IAGP
ClinVar Annotator: match by term: Asthma-related traits, susceptibility to, 2
ClinVar
PMID:15073379
NCBI chr 7:34,346,512...34,834,331
Ensembl chr 7:34,287,269...34,871,582
G
NPY
neuropeptide Y
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:9731035
NCBI chr 7:24,284,190...24,291,862
Ensembl chr 7:24,284,188...24,291,862
G
NQO1
NAD(P)H quinone dehydrogenase 1
susceptibility
IDA EXP IAGP
DNA:SNP:exon:c. 609C>T (human) CTD Direct Evidence: marker/mechanism DNA:SNP:exon:c.609C>T (human)
CTD RGD
PMID:20049212 PMID:19027876 PMID:19591959
RGD:5135006 , RGD:5135005
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
NR3C1
nuclear receptor subfamily 3 group C member 1
treatment severity susceptibility
IEP ISO IDA IAGP
protein:increased expression, decreased activity:leukocyte, mononuclear DNA:polymorphism:intron
RGD
PMID:18396779 PMID:28297812 PMID:20727335 PMID:18799869 PMID:15295049 PMID:21113676 More...
RGD:4892328 , RGD:408364991 , RGD:7174728 , RGD:4892594 , RGD:4892609 , RGD:4892568
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
G
NTF3
neurotrophin 3
IDA ISO
protein:increased expression:lung, serum
RGD
PMID:11737043 PMID:17497413
RGD:4891123 , RGD:4891068
NCBI chr12:5,430,332...5,495,299
Ensembl chr12:5,432,108...5,521,536
G
NTF4
neurotrophin 4
ISO
protein:increased expression:lung, serum
RGD
PMID:17497413
RGD:4891068
NCBI chr19:49,058,284...49,065,035
Ensembl chr19:49,061,066...49,065,076
G
NTRK1
neurotrophic receptor tyrosine kinase 1
ISO
mRNA:increased expression:lung:
RGD
PMID:20934630 PMID:16708804
RGD:5684766 , RGD:5684772
NCBI chr 1:156,815,750...156,881,850
Ensembl chr 1:156,815,636...156,881,850
G
ORMDL3
ORMDL sphingolipid biosynthesis regulator 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21150878 PMID:25256354
NCBI chr17:39,921,041...39,927,601
Ensembl chr17:39,921,041...39,927,601
G
P2RY12
purinergic receptor P2Y12
IAGP ISO
RGD
PMID:22010907 PMID:19822647
RGD:6480532 , RGD:6480533
NCBI chr 3:151,336,843...151,384,753
Ensembl chr 3:151,336,843...151,384,753
G
PARP1
poly(ADP-ribose) polymerase 1
treatment
ISO EXP IDA
CTD Direct Evidence: marker/mechanism protein:increased activation:lung, blood, mononuclear cell
CTD RGD
PMID:18261157 PMID:12594058 PMID:26205779 PMID:26205779
RGD:5683910 , RGD:11073727 , RGD:11073727
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
G
PDCD1
programmed cell death 1
treatment
ISO
associated with Chlamydia pneumonia
RGD
PMID:26378990
RGD:41412180
NCBI chr 2:241,849,884...241,858,894
Ensembl chr 2:241,849,884...241,858,894
G
PDE4B
phosphodiesterase 4B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21912604
NCBI chr 1:65,792,510...66,374,579
Ensembl chr 1:65,792,514...66,374,579
G
PDE4D
phosphodiesterase 4D
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19426955 PMID:21611147
NCBI chr 5:58,969,038...60,522,128
Ensembl chr 5:58,969,038...60,522,120
G
PDGFB
platelet derived growth factor subunit B
ISO
protein: increased expression
RGD
PMID:21216974 PMID:21216974
RGD:6483071 , RGD:6483071
NCBI chr22:39,223,359...39,244,982
Ensembl chr22:39,223,359...39,244,982
G
PGF
placental growth factor
IDA
RGD
PMID:22268141
RGD:6483605
NCBI chr14:74,941,830...74,955,764
Ensembl chr14:74,941,834...74,955,626
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
ISO
RGD
PMID:18754810
RGD:6482695
NCBI chr 7:106,865,282...106,908,980
Ensembl chr 7:106,865,278...106,908,980
G
PIN1
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
ISO
RGD
PMID:18188456
RGD:8693422
NCBI chr19:9,835,318...9,849,689
Ensembl chr19:9,835,257...9,849,689
G
PLA2G4A
phospholipase A2 group IVA
ISO
RGD
PMID:15557087
RGD:1642462
NCBI chr 1:186,828,949...186,988,981
Ensembl chr 1:186,828,949...186,988,981
G
PLA2G7
phospholipase A2 group VII
IAGP EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10733466 PMID:10733466
RGD:1581025
NCBI chr 6:46,704,201...46,735,721
Ensembl chr 6:46,704,201...46,735,693
G
PLAU
plasminogen activator, urokinase
IEP EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21912604 PMID:18519237
RGD:4892037
NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
G
PPP2CA
protein phosphatase 2 catalytic subunit alpha
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22205926
NCBI chr 5:134,194,332...134,226,073
Ensembl chr 5:134,193,978...134,226,073
G
PRF1
perforin 1
ISO
RGD
PMID:22250087 PMID:21426642
RGD:6482815 , RGD:6482818
NCBI chr10:70,597,348...70,602,741
Ensembl chr10:70,597,348...70,602,759
G
PRG2
proteoglycan 2, pro eosinophil major basic protein
severity disease_progression no_association
IEP ISO
mRNA:increased expression:eosinophil: associated with cough;protein:increased expression:sputum: associated with viral infection;mRNA:increased expression:sputum:
RGD
PMID:16982448 PMID:22022864 PMID:24450586 PMID:11067904
RGD:13506941 , RGD:13506944 , RGD:13506943 , RGD:13506942
NCBI chr11:57,386,780...57,390,650
Ensembl chr11:57,386,780...57,390,650
G
PRMT1
protein arginine methyltransferase 1
ISO
mRNA:increased expression:lung
RGD
PMID:20423833
RGD:9491823
NCBI chr19:49,676,153...49,688,447
Ensembl chr19:49,675,786...49,689,029
G
PRMT2
protein arginine methyltransferase 2
ISO
mRNA:increased expression:lung, spleen
RGD
PMID:20423833
RGD:9491823
NCBI chr21:46,635,674...46,665,124
Ensembl chr21:46,635,595...46,665,685
G
PRMT3
protein arginine methyltransferase 3
ISO
mRNA:increased expression:lung
RGD
PMID:20423833
RGD:9491823
NCBI chr11:20,387,716...20,509,338
Ensembl chr11:20,387,558...20,509,338
G
PRMT5
protein arginine methyltransferase 5
ISO
mRNA:increased expression:lung, spleen
RGD
PMID:20423833
RGD:9491823
NCBI chr14:22,920,529...22,929,376
Ensembl chr14:22,920,525...22,929,408
G
PROC
protein C, inactivator of coagulation factors Va and VIIIa
treatment
IDA
RGD
PMID:26381519
RGD:11099992
NCBI chr 2:127,418,427...127,429,242
Ensembl chr 2:127,418,427...127,429,242
G
PTEN
phosphatase and tensin homolog
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:17982072
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
G
PTGDR
prostaglandin D2 receptor
susceptibility
IAGP
OMIM
NCBI chr14:52,267,698...52,280,914
Ensembl chr14:52,267,698...52,276,724
G
PTGDR2
prostaglandin D2 receptor 2
IAGP EXP ISO
CTD Direct Evidence: therapeutic Aspirin exacerbated asthma
CTD RGD
PMID:27103662 PMID:19392992 PMID:19796209 PMID:18757520
RGD:5135019 , RGD:5135020 , RGD:5135018
NCBI chr11:60,850,933...60,855,950
Ensembl chr11:60,850,933...60,855,950
G
PTGER3
prostaglandin E receptor 3
treatment
ISO
RGD
PMID:23221044
RGD:10043366
NCBI chr 1:70,852,358...71,047,816
Ensembl chr 1:70,852,353...71,047,816
G
PTGS2
prostaglandin-endoperoxide synthase 2
susceptibility severity
ISO IAGP IMP
mRNA:increased expression:lung DNA:SNP: :8473T>C (human) mRNA, protein:increased expression:lung: DNA:SNP: :rs689465 (human)
RGD
PMID:19878559 PMID:15316498 PMID:17573729 PMID:18097056 PMID:18489027 PMID:19342146 PMID:19862936 More...
RGD:5135514 , RGD:5143931 , RGD:5143923 , RGD:5135534 , RGD:5135526 , RGD:5135522 , RGD:5135515
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
PYHIN1
pyrin and HIN domain family member 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21804549
NCBI chr 1:158,931,552...158,990,870
Ensembl chr 1:158,930,796...158,977,059
G
RAD50
RAD50 double strand break repair protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24241537
NCBI chr 5:132,556,977...132,646,349
Ensembl chr 5:132,556,019...132,646,349
G
RHOA
ras homolog family member A
ISO
RGD
PMID:18391481
RGD:2298885
NCBI chr 3:49,359,145...49,411,976
Ensembl chr 3:49,359,139...49,412,998
G
RNASE3
ribonuclease A family member 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:8874658 PMID:12153692 PMID:12587966
NCBI chr14:20,891,385...20,892,348
Ensembl chr14:20,891,385...20,892,348
G
RUNX1
RUNX family transcription factor 1
IAGP
DNA:SNPs: :multiple
RGD
PMID:21803869
RGD:6482835
NCBI chr21:35,372,507...35,580,764
Ensembl chr21:34,787,801...36,004,667
G
RUNX3
RUNX family transcription factor 3
ISS
OMIM:600807
MouseDO
NCBI chr 1:24,899,511...24,965,138
Ensembl chr 1:24,899,511...24,965,121
G
SCGB1A1
secretoglobin family 1A member 1
susceptibility
ISO IAGP IEP
mRNA,protein:decreased expression:bronchial alveolar lavage fluid, lung: ClinVar Annotator: match by term: Asthma, susceptibility to associated with allergic rhinitis; DNA:SNP:exon:38G>A (human) protein:decreased expression:serum
ClinVar RGD
PMID:9550363 PMID:9643286 PMID:12100044 PMID:12921604 PMID:21255142 PMID:15467329 More...
RGD:5144052 , RGD:5144226 , RGD:5144148
NCBI chr11:62,419,033...62,423,195
Ensembl chr11:62,405,103...62,423,195
G
SCGB3A2
secretoglobin family 3A member 2
susceptibility severity no_association
IAGP EXP ISO IEP
DNA:SNP:promoter:-112G>A (human) CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Asthma, susceptibility to mRNA,protein:decreased expression:;lung protein:increased expression:sputum
CTD OMIM ClinVar RGD
PMID:11813133 PMID:11813133 PMID:15531759 PMID:16456148 PMID:17218572 PMID:18089940 PMID:18201431 More...
RGD:5144229 , RGD:5128690 , RGD:5144233 , RGD:5144232 , RGD:5144231 , RGD:5144230
NCBI chr 5:147,878,711...147,882,191
Ensembl chr 5:147,870,682...147,882,191
G
SELL
selectin L
ISO
RGD
PMID:21437035 PMID:21515793
RGD:5685685 , RGD:5685696
NCBI chr 1:169,690,667...169,711,620
Ensembl chr 1:169,690,665...169,711,702
G
SERPINA1
serpin family A member 1
ISO
Fisher rats, shown to exhibit hyperactive airway responses at 14 days of age, had higher transcript and protein levels of Serpina1 than same age Brown Norway rats.
RGD
PMID:20118217
RGD:5131869
NCBI chr14:94,376,747...94,390,635
Ensembl chr14:94,376,747...94,390,693
G
SERPINE1
serpin family E member 1
severity no_association susceptibility
IEP ISO IAGP
protein:increased expression:plasma protein:increased activity, increased expression:plasma, lung DNA:polymorphism:promoter:rs1799768 (human)
RGD
PMID:19703828 PMID:18594148 PMID:19604112 PMID:19063817
RGD:4144831 , RGD:4144836 , RGD:4144833 , RGD:4144832
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
SFTPA1
surfactant protein A1
ISO IEP
protein:decreased expression:lung, Clara cell, pneumocyte mRNA, protein:increased expression:lung
RGD
PMID:15816355 PMID:16629790 PMID:18926058 PMID:18802356
RGD:4143398 , RGD:4143462 , RGD:4143289 , RGD:4143516
NCBI chr10:79,610,939...79,615,455
Ensembl chr10:79,610,939...79,615,455
G
SFTPB
surfactant protein B
IEP ISO
protein:increased expression:lung mRNA, protein:decreased expression:lung protein:decreased expression:lung, Clara cell
RGD
PMID:16629790 PMID:11472974 PMID:15816355 PMID:18926058
RGD:4143462 , RGD:4143465 , RGD:4143398 , RGD:4143289
NCBI chr 2:85,657,307...85,668,741
Ensembl chr 2:85,657,314...85,668,741
G
SFTPC
surfactant protein C
susceptibility
IAGP IEP ISO
DNA:polymorphism: :p.A53T (human) protein:increased expression:lung mRNA, protein:decreased expression:lung
RGD
PMID:19910179 PMID:16629790 PMID:11472974
RGD:4144063 , RGD:4143462 , RGD:4143465
NCBI chr 8:22,157,383...22,164,479
Ensembl chr 8:22,156,913...22,164,479
G
SFTPD
surfactant protein D
IEP ISO IDA
associated with Bronchitis;protein:increased expression:lung mRNA, protein:increased expression:lung
RGD
PMID:18266831 PMID:11472974 PMID:16839409 PMID:16629790 PMID:18802356
RGD:4143517 , RGD:4143465 , RGD:4143508 , RGD:4143462 , RGD:4143516
NCBI chr10:79,937,740...79,982,383
Ensembl chr10:79,937,467...79,982,614
G
SLC11A1
solute carrier family 11 member 1
ISO
RGD
PMID:12847242
RGD:5684966
NCBI chr 2:218,382,273...218,396,894
Ensembl chr 2:218,382,029...218,396,894
G
SLC18A3
solute carrier family 18 member A3
ISO
RGD
PMID:17328924
RGD:5686690
NCBI chr10:49,610,310...49,612,720
Ensembl chr10:49,610,310...49,612,720
G
SLC22A1
solute carrier family 22 member 1
ISO
RGD
PMID:17328924
RGD:5686690
NCBI chr 6:160,121,815...160,158,718
Ensembl chr 6:160,121,815...160,158,718
G
SLC5A7
solute carrier family 5 member 7
ISO
mRNA:decreased expression:lung
RGD
PMID:17328924
RGD:5686690
NCBI chr 2:107,986,524...108,013,994
Ensembl chr 2:107,986,523...108,013,994
G
SLC6A4
solute carrier family 6 member 4
susceptibility
IAGP
DNA:repeat:intron (human)
RGD
PMID:19806585
RGD:4889460
NCBI chr17:30,194,319...30,235,697
Ensembl chr17:30,194,319...30,236,002
G
SOD1
superoxide dismutase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22867017
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
G
SOD2
superoxide dismutase 2
IDA
RGD
PMID:15743779
RGD:1581231
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
G
SPRR2B
small proline rich protein 2B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21912604
NCBI chr 1:153,070,226...153,087,799
Ensembl chr 1:153,070,226...153,071,611
G
STAT4
signal transducer and activator of transcription 4
treatment
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:28807506 PMID:18211752
RGD:2317290
NCBI chr 2:191,029,576...191,151,596
Ensembl chr 2:191,029,576...191,178,435
G
STAT6
signal transducer and activator of transcription 6
treatment
ISO
RGD
PMID:19087723 PMID:16083555
RGD:7244151 , RGD:7244153
NCBI chr12:57,095,408...57,111,362
Ensembl chr12:57,095,408...57,132,139
G
TAC1
tachykinin precursor 1
IEP
protein:increased expression:lung
RGD
PMID:11031342
RGD:5147836
NCBI chr 7:97,732,086...97,740,472
Ensembl chr 7:97,732,084...97,740,472
G
TACR1
tachykinin receptor 1
ISO IEP
protein:increased expression:lung mRNA:increased expression:lung mRNA,protein:increased expression:lung
RGD
PMID:17392578 PMID:8240667 PMID:16409782
RGD:2304339 , RGD:5147645 , RGD:5147475
NCBI chr 2:75,046,463...75,199,520
Ensembl chr 2:75,046,463...75,199,520
G
TACR2
tachykinin receptor 2
IAGP IMP
DNA:SNP:cds:p.G231E (human)
RGD
PMID:20175803 PMID:19880429
RGD:5147640 , RGD:5147641
NCBI chr10:69,403,903...69,416,918
Ensembl chr10:69,403,903...69,416,918
G
TAP1
transporter 1, ATP binding cassette subfamily B member
susceptibility
IAGP
DNA:polymorphism: :
RGD
PMID:12640628
RGD:5147845
NCBI chr 6:32,845,209...32,853,704
Ensembl chr 6:32,845,209...32,853,816
G
TBX21
T-box transcription factor 21
EXP ISS
CTD Direct Evidence: marker/mechanism OMIM:600807
CTD MouseDO
PMID:15806396
NCBI chr17:47,733,236...47,746,122
Ensembl chr17:47,733,236...47,746,122
G
TBXA2R
thromboxane A2 receptor
susceptibility severity
IEA IAGP
ClinVar Annotator: match by term: Asthma DNA:polymorphism:cds:924T>C(human)
ClinVar RGD
PMID:2955539 PMID:7929844 PMID:8428006 PMID:8613548 PMID:15118671 PMID:12000493 PMID:15805995 More...
RGD:1331525 , RGD:11059535 , RGD:11059534
NCBI chr19:3,594,507...3,606,875
Ensembl chr19:3,594,507...3,606,875
G
TGFB1
transforming growth factor beta 1
onset no_association
IAGP EXP ISO IEP
DNA:SNP: :-509C>T (human) CTD Direct Evidence: marker/mechanism DNA:SNP:cds:915G>C (human) protein:increased expression:serum mRNA:increased expression:lung DNA:SNPs:promoter, exon:multiple (human) DNA:polymorphism: :-509C>T (human) DNA:polymorphisms: :multiple (human)
CTD RGD
PMID:16365456 PMID:19138248 PMID:17673695 PMID:18366906 PMID:19620629 PMID:19046298 PMID:19317336 PMID:20485865 PMID:19096005 PMID:18711258 PMID:19136038 PMID:19222424 PMID:19533439 More...
RGD:4145295 , RGD:4145280 , RGD:4145132 , RGD:4145142 , RGD:4145139 , RGD:4145113 , RGD:4145143 , RGD:4143443 , RGD:4145144 , RGD:4145299 , RGD:4145297
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
THBD
thrombomodulin
IDA
RGD
PMID:20709825
RGD:5684984
NCBI chr20:23,045,633...23,049,672
Ensembl chr20:23,045,633...23,049,672
G
TIMP3
TIMP metallopeptidase inhibitor 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16926187
NCBI chr22:32,801,705...32,863,041
Ensembl chr22:32,801,705...32,863,041
G
TLR1
toll like receptor 1
susceptibility
IAGP
DNA:SNP (human)
RGD
PMID:18547625
RGD:4889528
NCBI chr 4:38,787,569...38,805,644
Ensembl chr 4:38,787,555...38,856,817
G
TLR10
toll like receptor 10
susceptibility
IAGP
DNA:SNP (human)
RGD
PMID:18547625
RGD:4889528
NCBI chr 4:38,772,238...38,782,990
Ensembl chr 4:38,772,238...38,782,990
G
TLR2
toll like receptor 2
severity susceptibility
IAGP ISO
DNA:SNP: :rs3804100 (human) DNA:polymorphism:cds:p.R753Q(human) DNA:SNP: :rs4696480 (human) DNA:SNP: :rs7656411 (human) DNA:SNP: :596T>C (human)
RGD
PMID:19148143 PMID:22402138 PMID:18202345 PMID:20685742 PMID:20815312 PMID:18787777 PMID:19096003 More...
RGD:2312679 , RGD:7800732 , RGD:4145343 , RGD:4144171 , RGD:4145352 , RGD:4145334 , RGD:4144228
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,050...153,706,260
G
TLR3
toll like receptor 3
no_association
IEP IAGP ISO
Asthma, Virus-Induced; mRNA:increased expression:sputum (human) DNA:snp:cds:p.L412F (human)
RGD
PMID:21129050 PMID:14987294 PMID:17610940 PMID:21364926 PMID:17434873
RGD:5129226 , RGD:5129493 , RGD:5129475 , RGD:5128500 , RGD:5129478
NCBI chr 4:186,069,156...186,088,073
Ensembl chr 4:186,068,911...186,088,073
G
TLR4
toll like receptor 4
susceptibility no_association severity
IAGP ISO IEP
DNA:Polymorphism:cds:p.D299G (human) protein:decreased expression:leukocytes, mononuclear DNA:SNPs: :rs10983755, rs1927914 (human) DNA:SNPs:: DNA:polymorphisms:cds:c.896A>G, 1196C>T (human)
RGD
PMID:15356557 PMID:20628601 PMID:19067129 PMID:19330007 PMID:19159017 PMID:20685742 PMID:16266379 More...
RGD:4144817 , RGD:4144176 , RGD:4144190 , RGD:4144141 , RGD:4144188 , RGD:4144171 , RGD:4144198
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TLR6
toll like receptor 6
susceptibility
IAGP
DNA:SNP: :p.S249P (human) DNA:SNP (human)
RGD
PMID:15266299 PMID:18547625
RGD:4889538 , RGD:4889528
NCBI chr 4:38,822,897...38,868,390
Ensembl chr 4:38,822,897...38,856,817
G
TLR9
toll like receptor 9
susceptibility severity no_association
IAGP ISO IEP
DNA:SNP:promoter:g.-1237T>C (rs5743836) (human) protein:increased expression:peripheral blood mononuclear cell (human) DNA:SNP:promoter:g.-1237T>C rs5743836 (human)
RGD
PMID:18312481 PMID:20016192 PMID:20072849 PMID:21324137
RGD:4144208 , RGD:5129104 , RGD:4889523 , RGD:5130712
NCBI chr 3:52,221,080...52,225,645
Ensembl chr 3:52,221,080...52,225,645
G
TNC
tenascin C
ISO EXP IAGP IEP
CTD Direct Evidence: marker/mechanism DNA:SNPs: :multiple (human) DNA:SNP:exon:p.L1677I (human) protein:increased expression:bronchus basement membrane
CTD RGD
PMID:16115819 PMID:17125141 PMID:18305139 PMID:16115819 PMID:9310019
RGD:4889565 , RGD:4889589 , RGD:4889569 , RGD:4889572
NCBI chr 9:115,019,575...115,118,157
Ensembl chr 9:115,019,575...115,118,207
G
TNF
tumor necrosis factor
susceptibility no_association
IAGP EXP ISO IEP
associated with obesity; DNA:polymorphism:promoter ClinVar Annotator: match by term: Asthma, susceptibility to CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter: c. -308A>G (human) DNA:polymorphisms:: rs1799964, rs1799724 (human) DNA:polymorphisms: : associated with nasal polys; protein:increased expression:nose DNA:polymorphism:promoter:c.-863C > A (human)
OMIM ClinVar CTD RGD
PMID:8056188 PMID:9818939 PMID:10450718 PMID:11261930 PMID:11506397 PMID:11826025 PMID:11896460 PMID:12356572 PMID:12485196 PMID:12746914 PMID:12759288 PMID:14681301 PMID:14718719 PMID:16418737 PMID:16456144 PMID:16720636 PMID:16865291 PMID:16909270 PMID:17450233 PMID:18050183 PMID:18713756 PMID:19365401 PMID:20049212 PMID:22760475 PMID:22992668 PMID:19196817 PMID:18711258 PMID:12530118 PMID:18811622 PMID:16393274 PMID:18763028 PMID:20465535 PMID:16728705 More...
RGD:4143238 , RGD:4143443 , RGD:4143254 , RGD:4143240 , RGD:4145508 , RGD:4142802 , RGD:4143369 , RGD:4143372
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFRSF1A
TNF receptor superfamily member 1A
ISO
protein:increased expression:lung (mouse)
RGD
PMID:20484920
RGD:5131201
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
G
TNIP1
TNFAIP3 interacting protein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24453940
NCBI chr 5:151,029,943...151,087,685
Ensembl chr 5:151,029,945...151,093,577
G
TRPA1
transient receptor potential cation channel subfamily A member 1
severity
EXP ISO
CTD Direct Evidence: marker/mechanism ovalbumin sensitization
CTD RGD
PMID:19458046 PMID:31969645
RGD:127285811
NCBI chr 8:72,021,250...72,090,010
Ensembl chr 8:72,019,917...72,075,584
G
TSLP
thymic stromal lymphopoietin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21804549
NCBI chr 5:111,070,062...111,078,026
Ensembl chr 5:111,070,062...111,078,026
G
UCN
urocortin
ISO
associated with Hypersensitivity;mRNA, protein:increased expression:lung
RGD
PMID:16427607
RGD:1642781
NCBI chr 2:27,307,400...27,308,445
Ensembl chr 2:27,307,400...27,308,445
G
UTS2
urotensin 2
IEP
RGD
PMID:17045018
RGD:2306832
NCBI chr 1:7,847,612...7,913,249
Ensembl chr 1:7,843,083...7,853,512
G
VDR
vitamin D receptor
no_association
IAGP
DNA:SNPs (human) DNA:SNP: :rs7975232 (human) DNA:SNPs: :multiple (human) DNA:SNP (human)
RGD
PMID:20124605 PMID:19622139 PMID:15282200 PMID:21103062
RGD:4889867 , RGD:4889868 , RGD:4889854 , RGD:4889866
NCBI chr12:47,841,537...47,904,994
Ensembl chr12:47,841,537...47,943,048
G
VEGFA
vascular endothelial growth factor A
IEP EXP
protein:increased expression:sputum CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11907124 PMID:15201500 PMID:19263519 PMID:19178538
RGD:6892723
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
VIP
vasoactive intestinal peptide
ISO
RGD
PMID:21419198 PMID:16782752
RGD:5685381 , RGD:5685620
NCBI chr 6:152,750,797...152,759,760
Ensembl chr 6:152,750,797...152,759,765
G
WDR36
WD repeat domain 36
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19198610
NCBI chr 5:111,092,348...111,130,502
Ensembl chr 5:111,092,321...111,130,502
G
CXCL8
C-X-C motif chemokine ligand 8
treatment
IEP
RGD
PMID:30059697
RGD:39939057
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CCL26
C-C motif chemokine ligand 26
treatment
ISO
RGD
PMID:25530546
RGD:11081163
NCBI chr 7:75,769,524...75,791,597
Ensembl chr 7:75,769,533...75,789,896
G
CYSLTR1
cysteinyl leukotriene receptor 1
treatment
ISO
RGD
PMID:23933317
RGD:40903070
NCBI chr X:78,271,468...78,327,611
Ensembl chr X:78,271,468...78,327,691
G
EPX
eosinophil peroxidase
IEP
protein:increased expression:urine:
RGD
PMID:11846868
RGD:13506893
NCBI chr17:58,192,726...58,205,174
Ensembl chr17:58,192,726...58,205,174
G
HLA-B
major histocompatibility complex, class I, B
susceptibility
IAGP
DNA:polymorphism:
RGD
PMID:28380482
RGD:13506910
NCBI chr 6:31,353,875...31,357,179
Ensembl chr 6:31,353,872...31,367,067
G
HLA-C
major histocompatibility complex, class I, C
susceptibility
IAGP
DNA:polymorphism:
RGD
PMID:28380482
RGD:13506910
NCBI chr 6:31,268,749...31,272,092
Ensembl chr 6:31,268,749...31,272,130
G
HLA-DPA1
major histocompatibility complex, class II, DP alpha 1
susceptibility
IAGP
DNA:polymorphism:
RGD
PMID:28380482
RGD:13506910
NCBI chr 6:33,064,569...33,080,748
Ensembl chr 6:33,064,569...33,080,775
G
HLA-DPB1
major histocompatibility complex, class II, DP beta 1
susceptibility
IAGP
DNA:polymorphism:
RGD
PMID:28380482
RGD:13506910
NCBI chr 6:33,075,990...33,089,696
Ensembl chr 6:33,075,936...33,089,696
G
HLA-DRB1
major histocompatibility complex, class II, DR beta 1
susceptibility
IAGP
RGD
PMID:22397267
RGD:13506905
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
G
IL25
interleukin 25
treatment
ISO
RGD
PMID:17889290
RGD:40902975
NCBI chr14:23,372,809...23,376,403
Ensembl chr14:23,372,809...23,376,403
G
TREM1
triggering receptor expressed on myeloid cells 1
exacerbates
ISO
RGD
PMID:21592044 PMID:21592044
RGD:126928124 , RGD:126928124
NCBI chr 6:41,267,385...41,286,682
Ensembl chr 6:41,267,100...41,286,682
G
CACNG6
calcium voltage-gated channel auxiliary subunit gamma 6
susceptibility
IAGP
DNA:SNP,haplotype:rs192808(human)
RGD
PMID:20860846
RGD:13524562
NCBI chr19:53,991,149...54,012,666
Ensembl chr19:53,991,637...54,012,666
G
CCR3
C-C motif chemokine receptor 3
IEP EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20485159 PMID:20022477
RGD:4145619
NCBI chr 3:46,210,696...46,266,706
Ensembl chr 3:46,130,890...46,266,706
G
CYSLTR1
cysteinyl leukotriene receptor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16502481 PMID:17641958 PMID:20485159
NCBI chr X:78,271,468...78,327,611
Ensembl chr X:78,271,468...78,327,691
G
CYSLTR2
cysteinyl leukotriene receptor 2
IAGP EXP
DNA:SNPs: :-819T>G, 2078C>T, 2534A>G (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16502481 PMID:20485159 PMID:15970796
RGD:5144000
NCBI chr13:48,653,929...48,711,226
Ensembl chr13:48,653,711...48,711,226
G
FANCC
FA complementation group C
IAGP
DNA:haplotype::rs4647416(human)
RGD
PMID:21670957
RGD:11045795
NCBI chr 9:95,099,054...95,317,709
Ensembl chr 9:95,099,054...95,426,796
G
HLA-DPB1
major histocompatibility complex, class II, DP beta 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16502481
NCBI chr 6:33,075,990...33,089,696
Ensembl chr 6:33,075,936...33,089,696
G
HLA-DQA1
major histocompatibility complex, class II, DQ alpha 1
susceptibility
IAGP
RGD
PMID:25975240
RGD:11074090
NCBI chr 6:32,637,406...32,655,272
Ensembl chr 6:32,628,179...32,647,062
G
HLA-DQB1
major histocompatibility complex, class II, DQ beta 1
susceptibility
IAGP
RGD
PMID:25975240
RGD:11074090
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
G
HLA-DRB1
major histocompatibility complex, class II, DR beta 1
susceptibility
IAGP
RGD
PMID:25975240
RGD:11074090
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
G
HLA-DRB3
major histocompatibility complex, class II, DR beta 3
susceptibility
IAGP
RGD
PMID:25975240
RGD:11074090
G
HLA-DRB4
major histocompatibility complex, class II, DR beta 4
susceptibility
IAGP
RGD
PMID:25975240
RGD:11074090
G
IL4
interleukin 4
susceptibility
IAGP
DNA:SNPs:promoter,5'UTR,intron:multiple
RGD
PMID:20921925
RGD:11528633
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
LOC109286563
TBX21 promoter region
IAGP
ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to
ClinVar
PMID:15806396
NCBI chr17:47,731,244...47,733,594
G
LTC4S
leukotriene C4 synthase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:9393345 PMID:9466979 PMID:10970818 PMID:20485159
NCBI chr 5:179,793,986...179,796,647
Ensembl chr 5:179,793,980...179,796,647
G
MS4A2
membrane spanning 4-domains A2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16502481
NCBI chr11:60,088,259...60,098,467
Ensembl chr11:60,088,261...60,098,467
G
POSTN
periostin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18391768
NCBI chr13:37,562,585...37,598,768
Ensembl chr13:37,562,583...37,598,844
G
PTGDR2
prostaglandin D2 receptor 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20485159
NCBI chr11:60,850,933...60,855,950
Ensembl chr11:60,850,933...60,855,950
G
PTGER2
prostaglandin E receptor 2
IAGP EXP
ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar CTD
PMID:15496426 PMID:16502481
NCBI chr14:52,314,312...52,328,598
Ensembl chr14:52,314,305...52,329,822
G
PTGIR
prostaglandin I2 receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20485159
NCBI chr19:46,610,687...46,625,089
Ensembl chr19:46,618,550...46,625,089
G
PTGS2
prostaglandin-endoperoxide synthase 2
IEP EXP
protein:increased expression:mast cell CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16502481 PMID:20485159 PMID:9487340
RGD:5143936
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
TAP2
transporter 2, ATP binding cassette subfamily B member
IAGP
RGD
PMID:21796142
RGD:5147839
NCBI chr 6:32,821,831...32,838,739
Ensembl chr 6:32,821,833...32,838,739
G
TBX21
T-box transcription factor 21
IAGP EXP
ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar CTD
PMID:15806396 PMID:16502481
NCBI chr17:47,733,236...47,746,122
Ensembl chr17:47,733,236...47,746,122
G
TBXA2R
thromboxane A2 receptor
susceptibility
IAGP EXP
DNA:polymorphism: :795T>C (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16502481 PMID:20485159 PMID:15898979
RGD:11059537
NCBI chr19:3,594,507...3,606,875
Ensembl chr19:3,594,507...3,606,875
G
HLA-DRA
major histocompatibility complex, class II, DR alpha
susceptibility
IAGP
DNA:SNPs,haplotype:introns:
RGD
PMID:22391069
RGD:13506908
NCBI chr 6:32,439,887...32,445,046
Ensembl chr 6:32,439,878...32,445,046
G
LOC109286563
TBX21 promoter region
IAGP
ClinVar Annotator: match by term: Asthma and nasal polyps
ClinVar
PMID:15806396
NCBI chr17:47,731,244...47,733,594
G
TBX21
T-box transcription factor 21
IAGP
ClinVar Annotator: match by term: Asthma and nasal polyps
ClinVar
PMID:15806396
NCBI chr17:47,733,236...47,746,122
Ensembl chr17:47,733,236...47,746,122
G
ALOX15
arachidonate 15-lipoxygenase
IAGP
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance
ClinVar
PMID:17959182 PMID:21558275 PMID:25741868 PMID:30643255
NCBI chr17:4,630,919...4,641,678
Ensembl chr17:4,630,919...4,642,294
G
LOC109286563
TBX21 promoter region
IAGP
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance
ClinVar
PMID:25741868
NCBI chr17:47,731,244...47,733,594
G
LOC130061064
ATAC-STARR-seq lymphoblastoid silent region 8640
IAGP
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance
ClinVar
PMID:25741868
NCBI chr17:47,733,625...47,733,794
G
LTC4S
leukotriene C4 synthase
IAGP
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance
ClinVar
PMID:25741868
NCBI chr 5:179,793,986...179,796,647
Ensembl chr 5:179,793,980...179,796,647
G
PTGER2
prostaglandin E receptor 2
susceptibility
IAGP EXP
CTD Direct Evidence: marker/mechanism
OMIM CTD
NCBI chr14:52,314,312...52,328,598
Ensembl chr14:52,314,305...52,329,822
G
TBX21
T-box transcription factor 21
susceptibility
EXP IAGP
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance
CTD OMIM ClinVar
PMID:25741868
NCBI chr17:47,733,236...47,746,122
Ensembl chr17:47,733,236...47,746,122
G
NFKBIA
NFKB inhibitor alpha
exacerbates
IAGP
associated with respiratory syncytial virus infectious disease;DNA:SNPs:protomer: (rs2233409) (human)
RGD
PMID:23487427
RGD:40902982
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
G
NGF
nerve growth factor
treatment
ISO
RGD
PMID:30681402
RGD:405100716
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
G
CCL26
C-C motif chemokine ligand 26
severity
IEP
protein:increased expression:sputum (human)
RGD
PMID:25936567
RGD:11531115
NCBI chr 7:75,769,524...75,791,597
Ensembl chr 7:75,769,533...75,789,896
G
EPX
eosinophil peroxidase
treatment
IDA
RGD
PMID:28751233
RGD:13506890
NCBI chr17:58,192,726...58,205,174
Ensembl chr17:58,192,726...58,205,174
G
ALOX5
arachidonate 5-lipoxygenase
IMP
RGD
PMID:10984370
RGD:4890423
NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119
G
CCL5
C-C motif chemokine ligand 5
IEP
protein:increased secretion:lung, secretion (human)
RGD
PMID:19996575
RGD:4892021
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
TACR1
tachykinin receptor 1
IMP
RGD
PMID:8630576
RGD:5147837
NCBI chr 2:75,046,463...75,199,520
Ensembl chr 2:75,046,463...75,199,520
G
ACSL3
acyl-CoA synthetase long chain family member 3
ISO
RGD
PMID:23526225
RGD:13831300
NCBI chr 2:222,861,036...222,944,639
Ensembl chr 2:222,860,942...222,944,639
G
BCL2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:29713367
RGD:13792581
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
CD86
CD86 molecule
treatment
ISO
RGD
PMID:25344652
RGD:11354965
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
G
FAS
Fas cell surface death receptor
treatment
ISO
RGD
PMID:29713367
RGD:13792581
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
G
FASLG
Fas ligand
treatment
ISO
RGD
PMID:29713367
RGD:13792581
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
G
IL23A
interleukin 23 subunit alpha
ISO
RGD
PMID:19935773 PMID:26344076
RGD:5037240 , RGD:11251537
NCBI chr12:56,338,884...56,340,410
Ensembl chr12:56,334,174...56,340,410
G
AGER
advanced glycosylation end-product specific receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:33075463
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
G
CDH17
cadherin 17
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25918132
NCBI chr 8:94,127,162...94,217,278
Ensembl chr 8:94,127,162...94,217,303
G
HERC2
HECT and RLD domain containing E3 ubiquitin protein ligase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25918132
NCBI chr15:28,111,040...28,322,179
Ensembl chr15:28,111,040...28,322,179
G
HLA-B
major histocompatibility complex, class I, B
susceptibility
IAGP
DNA:SNP: :rs1811197(human)
RGD
PMID:24709764
RGD:13506912
NCBI chr 6:31,353,875...31,357,179
Ensembl chr 6:31,353,872...31,367,067
G
HLA-DOA
major histocompatibility complex, class II, DO alpha
treatment
IAGP
DNA:SNP: :rs3128935(human)
RGD
PMID:24709764
RGD:13506912
NCBI chr 6:33,004,182...33,009,591
Ensembl chr 6:33,004,182...33,009,591
G
HLA-DPB1
major histocompatibility complex, class II, DP beta 1
susceptibility
IAGP
DNA:SNP: : rs928976(human)
RGD
PMID:24709764
RGD:13506912
NCBI chr 6:33,075,990...33,089,696
Ensembl chr 6:33,075,936...33,089,696
G
HLA-E
major histocompatibility complex, class I, E
susceptibility
IAGP
DNA:SNP: :rs1573294(human)
RGD
PMID:24709764
RGD:13506912
NCBI chr 6:30,489,509...30,494,194
Ensembl chr 6:30,489,509...30,494,194
G
PLA2G4A
phospholipase A2 group IVA
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:27504716
NCBI chr 1:186,828,949...186,988,981
Ensembl chr 1:186,828,949...186,988,981
G
PRKCA
protein kinase C alpha
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:27504716
NCBI chr17:66,302,613...66,810,743
Ensembl chr17:66,302,613...66,810,743
G
PRKD1
protein kinase D1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:27504716
NCBI chr14:29,576,479...29,927,847
Ensembl chr14:29,576,479...30,191,898
G
PTGS1
prostaglandin-endoperoxide synthase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25721048
NCBI chr 9:122,370,533...122,395,703
Ensembl chr 9:122,370,530...122,395,703
G
PTGS2
prostaglandin-endoperoxide synthase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25721048
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
TENM3
teneurin transmembrane protein 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25918132
NCBI chr 4:181,447,613...182,803,024
Ensembl chr 4:182,143,987...182,803,024
G
TGFB1
transforming growth factor beta 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25721048
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
TNF
tumor necrosis factor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25721048
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
PLA2G7
phospholipase A2 group VII
IAGP EXP
ClinVar Annotator: match by term: Platelet-activating factor acetylhydrolase deficiency CTD Direct Evidence: marker/mechanism
ClinVar OMIM CTD
PMID:8675689 PMID:9412624 PMID:10194471 PMID:10733466 PMID:16787988 PMID:25741868 PMID:28406212 More...
NCBI chr 6:46,704,201...46,735,721
Ensembl chr 6:46,704,201...46,735,693
G
IFNG
interferon gamma
resistance
ISO
RGD
PMID:20817868
RGD:4145651
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IL1B
interleukin 1 beta
IEP
protein:increased expression:lung
RGD
PMID:9927362
RGD:4143184
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL5
interleukin 5
IEP
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:10934091
RGD:4890960
NCBI chr 5:132,541,445...132,556,815
Ensembl chr 5:132,541,445...132,556,838
G
MPO
myeloperoxidase
IEP
protein:increased expression:serum
RGD
PMID:10731862
RGD:5130994
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all